Disease by etiologic mechanism
MONDO:7770008A grouping class for human diseases classified by their etiologic mechanism, encompassing primarily intrinsic (genetic, genomic), primarily extrinsic (e.g., infections, toxins, radiation), and complex multifactorial (e.g. nutritional) causes.
60180 clinical trials for this condition and its sub-types, 0 tagged with Disease by etiologic mechanism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Disease by etiologic mechanism
-
Cancer or benign tumor 0 trials · 33,117 incl. sub-types
5 sub-types
- Neoplastic disease or syndrome 7 trials · 32,782 incl. sub-types Sub-types →
- Precancerous condition 51 trials · 518 incl. sub-types Sub-types →
- Hyperplasia 5 trials · 273 incl. sub-types Sub-types →
- Polyp 14 trials · 202 incl. sub-types Sub-types →
- Cancer-related condition 16 trials · 36 incl. sub-types Sub-types →
-
Disease of genetic or genomic mechanism 2 trials · 18,379 incl. sub-types
2 sub-types
- Hereditary disease 194 trials · 18,235 incl. sub-types Sub-types →
- Chromosomal disorder 13 trials · 278 incl. sub-types Sub-types →
-
Disease of primarily extrinsic mechanism 0 trials · 10,609 incl. sub-types
7 sub-types
- Infectious disease 298 trials · 8,231 incl. sub-types Sub-types →
- Post-infectious disorder 2 trials · 1,773 incl. sub-types Sub-types →
- Disease related to transplantation 30 trials · 538 incl. sub-types Sub-types →
- Poisoning 70 trials · 313 incl. sub-types Sub-types →
- Occupational disorder 59 trials · 171 incl. sub-types Sub-types →
- Iatrogenic disease 19 trials · 136 incl. sub-types Sub-types →
- Radiation-induced disorder 7 trials · 93 incl. sub-types Sub-types →
-
Nutritional disorder 132 trials · 4,176 incl. sub-types
7 sub-types
- Overnutrition 15 trials · 3,257 incl. sub-types Sub-types →
- Nutritional deficiency disease 239 trials · 512 incl. sub-types Sub-types →
- Eating disorder 157 trials · 362 incl. sub-types Sub-types →
- Lactose intolerance 9 trials · 10 incl. sub-types Sub-types →
- Potassium deficiency disease 4 trials · 5 incl. sub-types Sub-types →
- Refeeding syndrome 4 trials
- Hemorrhagic disease of newborn 1 trial
-
Idiopathic disease 1 trial · 1,285 incl. sub-types
79 sub-types
- Fibromyalgia 281 trials
- Idiopathic interstitial pneumonia 10 trials · 219 incl. sub-types Sub-types →
- Idiopathic scoliosis 66 trials · 181 incl. sub-types Sub-types →
- Acquired idiopathic inflammatory myopathy 67 trials · 159 incl. sub-types Sub-types →
- Juvenile idiopathic arthritis 107 trials · 115 incl. sub-types Sub-types →
- Idiopathic urticaria 0 trials · 66 incl. sub-types Sub-types →
- Idiopathic membranous glomerulonephritis 51 trials
- Idiopathic hypersomnia 28 trials Sub-types →
- Idiopathic nephrotic syndrome 13 trials · 24 incl. sub-types Sub-types →
- Sudden unexpected death in pediatrics 1 trial · 17 incl. sub-types Sub-types →
- Cellular phase chronic idiopathic myelofibrosis 16 trials
- Idiopathic pulmonary arterial hypertension 15 trials
- Idiopathic spontaneous coronary artery dissection 15 trials
- Idiopathic bilateral vestibulopathy 14 trials
- Idiopathic achalasia 12 trials
- Pediatric acute-onset neuropsychiatric syndrome 8 trials · 10 incl. sub-types Sub-types →
- Idiopathic aplastic anemia 9 trials
- Persistent idiopathic facial pain 9 trials
- Idiopathic gastroparesis 8 trials
- Idiopathic recurrent pericarditis 8 trials
- Idiopathic CD4 lymphocytopenia 7 trials
- Idiopathic camptocormia 7 trials
- Myelodysplastic syndrome with ring sideroblasts 7 trials
- Idiopathic CD4-positive T-lymphocytopenia 6 trials
- Idiopathic torsion dystonia 6 trials Sub-types →
- Chronic idiopathic neuropathy 5 trials
- Idiopathic malabsorption due to bile acid synthesis defects 4 trials
- Idiopathic bronchiectasis 3 trials Sub-types →
- Idiopathic cardiomyopathy 2 trials · 3 incl. sub-types Sub-types →
- Idiopathic hypercalciuria 3 trials
- Idiopathic anaphylaxis 1 trial
- Idiopathic avascular necrosis 1 trial
- Idiopathic central precocious puberty 1 trial
- Idiopathic mast cell activation syndrome 1 trial
- Idiopathic posterior uveitis 1 trial
- Macular telangiectasia type 1 1 trial
- Nonimmune chronic idiopathic neutropenia of adults 1 trial
- Basal ganglia calcification, idiopathic, 1 0 trials
- Basal ganglia calcification, idiopathic, 4 0 trials
- Basal ganglia calcification, idiopathic, 5 0 trials
- Basal ganglia calcification, idiopathic, 6 0 trials
- Basal ganglia calcification, idiopathic, 7, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 8, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, childhood-onset 0 trials
- Benign idiopathic neonatal seizures 0 trials
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia 0 trials
- Diffuse idiopathic skeletal hyperostosis 0 trials
- Edema, familial idiopathic, prepubertal 0 trials
- Familial idiopathic dilatation of the right atrium 0 trials
- Idiopathic acute transverse myelitis 0 trials
- Idiopathic anterior uveitis 0 trials
- Idiopathic congenital hypothyroidism 0 trials
- Idiopathic copper-associated cirrhosis 0 trials
- Idiopathic corneal edema 0 trials
- Idiopathic disseminated cytomegalovirus infection 0 trials
- Idiopathic dropped head syndrome 0 trials
- Idiopathic ductopenia 0 trials
- Idiopathic eosinophilic pneumonia 0 trials Sub-types →
- Idiopathic granulomatous myositis 0 trials
- Idiopathic hemiconvulsion-hemiplegia syndrome 0 trials
- Idiopathic juvenile osteoporosis 0 trials
- Idiopathic linear interstitial keratitis 0 trials
- Idiopathic localized lipodystrophy 0 trials
- Idiopathic neonatal atrial flutter 0 trials
- Idiopathic panuveitis 0 trials Sub-types →
- Idiopathic peliosis hepatis 0 trials
- Idiopathic peripheral autonomic neuropathy 0 trials
- Idiopathic phalangeal acro-osteolysis 0 trials
- Idiopathic progressive polyneuropathy 0 trials
- Idiopathic pulmonary artery dilatation 0 trials
- Idiopathic recurrent stupor 0 trials
- Idiopathic severe pneumococcemia 0 trials
- Idiopathic syringomyelia 0 trials
- Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 0 trials
- Macular telangiectasia type 3 0 trials
- Polyhydramnios, chronic idiopathic 0 trials
- Priapism, familial idiopathic 0 trials
- Recurrent idiopathic neuroretinitis 0 trials
- Tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 8181 trials in this tab.
-
Can a common antiseptic outperform standard wart treatment?
Cure Not yet recruitingResearchers compare two topical treatments for plantar warts: hydrogen peroxide 40% applied once weekly and salicylic acid 40% applied daily. The trial enrolls 70 people aged 12 and older with clinically diagnosed plantar warts. The main goal is to see how many participants achie…
Phase 3 • Sponsor: Assiut University • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
One shot of gene therapy aims to fix a rare Muscle-Weakening disease
Cure Not yet recruitingResearchers are testing AMP-101, an experimental gene therapy, in people with DOK7 congenital myasthenic syndrome, a rare inherited disorder that causes muscle weakness and exercise intolerance. About 4 participants with moderate to severe DOK7 CMS will receive a single intraveno…
Phase 1 • Sponsor: Amplo Biotechnology • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Laser zaps pilonidal sinus in minimally invasive procedure
Cure Not yet recruitingResearchers are testing a minimally invasive laser procedure to treat chronic pilonidal sinus, a painful condition near the tailbone. The trial enrolls adults with sinus tracts between 2 and 9 centimeters, excluding those with acute abscesses or prior surgery. During the procedur…
Sponsor: State Scientific Centre of Coloproctology, Russian Federation • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Half-Matched stem cell transplants tested as a cure path for older aplastic anemia patients
Cure Not yet recruitingResearchers are testing a conditioning regimen built around thiotepa before a haploidentical, or half-matched, stem cell transplant in people aged 50 and older with severe aplastic anemia. The regimen also includes busulfan, fludarabine, anti-thymocyte globulin, and basiliximab, …
Sponsor: Peking University People's Hospital • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Stem cells through the nose: a shot at stopping cerebral palsy
Cure Not yet recruitingNewborns who suffer a stroke or oxygen loss around birth can develop cerebral palsy and other lifelong disabilities, and no treatment can repair the damage. Researchers at UMC Utrecht are testing whether a single dose of bone marrow-derived mesenchymal stromal cells, sprayed into…
Phase 2/3 • Sponsor: UMC Utrecht • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
A Patient's own immune cells, grown in the lab, tested against advanced lung cancer
Cure Not yet recruitingResearchers are testing an experimental cell therapy called HS-IT101 in people with advanced non-small cell lung cancer. The treatment uses tumor-infiltrating lymphocytes (TILs), immune cells taken from the patient's own tumor, multiplied in the lab, and given back. Before receiv…
Phase 1 • Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Experimental therapy SNC116 put to the test against Hard-to-Treat leukemia
Cure Not yet recruitingResearchers are testing an experimental therapy called SNC116 in adults with B-cell acute lymphoblastic leukemia that has returned or stopped responding to treatment. The early-stage study enrolls about 28 people and focuses on safety, side effects, and how the body processes the…
Early phase 1 • Sponsor: Shanghai Simnova Biotechnology Co.,Ltd. • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Can a Patient's own immune cells fight back against recurrent brain cancer?
Cure Not yet recruitingResearchers are testing CHANK-101, a therapy made from a patient's own natural killer (NK) cells, in adults with glioblastoma that has returned after standard treatment. The study enrolls 60 participants who receive intravenous infusions of these cells every two weeks for up to 1…
Sponsor: Dong-A University Hospital • Aim: Cure
Last updated Sep 21, 2026 18:00 UTC
-
Experimental therapy aims to turn brain tumors against themselves
Cure Not yet recruitingResearchers are testing an experimental therapy called SRN-101 in adults with recurrent high-grade glioma, an aggressive brain cancer that has returned after standard treatment. Participants receive SRN-101 directly into the tumor before planned surgery to remove it. The trial's …
Phase 1 • Sponsor: Nicholas Butowski • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
One small incision vs several: robotic stomach cancer surgery put to the test
Cure Not yet recruitingResearchers are comparing two ways of performing robotic surgery to remove stomach cancer: a single-port approach and a standard multi-port approach. The trial enrolls 212 adults with stomach cancer that can be removed with distal gastrectomy. The main question is whether the sin…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can immunotherapy before surgery stop early oral cancer from returning?
Cure Not yet recruitingThis phase 3 trial tests whether adding sintilimab, an immunotherapy drug, to chemotherapy before surgery helps people with early-stage oral squamous cell carcinoma. Participants are adults aged 18 to 75 with cT2N0M0 oral cancer that can be removed by surgery. Half receive sintil…
Phase 3 • Sponsor: caohaotian • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Aortic graft used to rebuild windpipe in thyroid cancer surgery
Cure Not yet recruitingResearchers test a new surgical approach for thyroid cancer that has invaded the windpipe. They replace the affected section with a preserved aortic graft supported by a silicone stent. The goal is to remove all cancer and improve survival. The trial includes patients whose cance…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Experimental cell therapy targets Hard-to-Treat lymphoma
Cure Not yet recruitingResearchers are testing an experimental cell therapy called CT1190B in adults with large B-cell lymphoma that has returned or stopped responding to treatment. The trial enrolls up to 68 people aged 18 to 75 and gives the therapy by intravenous infusion. The main goals are to chec…
Phase 1/2 • Sponsor: UCARsgen Biotech Limited • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can two antibodies and a cancer drug free people with HIV from daily pills?
Cure Not yet recruitingResearchers are testing whether a combination of two long-acting HIV antibodies and a low dose of the cancer immunotherapy nivolumab can help people with HIV control the virus without antiretroviral therapy. The trial enrolls 90 adults whose HIV is already well suppressed on stan…
Phase 2 • Sponsor: Ole Schmeltz Søgaard • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
One-Time gene therapy aims to halt sanfilippo syndrome
Cure Not yet recruitingResearchers test a one-time gene therapy infusion in children and adults with Sanfilippo syndrome (MPS IIIB), a rare inherited disease that damages the brain and body. The therapy delivers a working copy of the NAGLU gene to help the body make an enzyme that is missing or faulty.…
Phase 1/2 • Sponsor: NeuroGT • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Off-the-Shelf CAR-T cells target CD70 in Hard-to-Treat blood cancers
Cure Not yet recruitingResearchers are testing CHT101, an experimental CAR-T cell therapy made from donor cells, in adults with T-cell or B-cell blood cancers that have come back or stopped responding to treatment. The therapy targets CD70, a marker found on these cancer cells. The Phase I trial aims t…
Phase 1 • Sponsor: Nanjing Miracle Biotechnology Co., Ltd. • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
Dengue vaccine takes on a controlled virus challenge
Vaccine Not yet recruitingResearchers are testing a new dengue vaccine called VLPDEN-02 in 42 healthy adults who have never had a flavivirus infection. The vaccine combines four virus-like particles, one for each dengue virus type, with an adjuvant to boost the immune response. Participants receive three …
Phase 1 • Sponsor: VLP Therapeutics • Aim: Vaccine
Last updated Sep 21, 2026 18:00 UTC
-
Malaria vaccines put to the test: can three new shots trigger protection?
Vaccine Not yet recruitingResearchers are testing three experimental malaria vaccines (LYB014, LYB017, and LYB027) in healthy adults aged 18 to 50. Participants receive either a low or high dose of one vaccine combined with an immune-boosting adjuvant, or the adjuvant alone as a comparison. The trial trac…
Phase 1 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: Vaccine
Last updated Sep 21, 2026 18:00 UTC
-
Could a vaccine shield HIV-Exposed newborns? early trial launches
Vaccine Not yet recruitingThis early-stage trial will test a new HIV vaccine in 22 infants who were exposed to HIV during birth but are not infected. The vaccine is designed to train the immune system to recognize and fight HIV. The main goal is to see if the vaccine is safe and whether it triggers an imm…
Phase 1 • Sponsor: HIV Vaccine Trials Network • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Nasal spray vaccine aims to stop COVID-19 at the source
Vaccine Not yet recruitingThis study tests a new type of COVID-19 booster vaccine given as a nasal spray. The vaccine uses a weakened live virus to train the immune system, potentially offering stronger protection in the nose and throat where the virus enters. Researchers are enrolling 80 healthy adults a…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Could a vaccine clear up severe teen acne?
Vaccine Not yet recruitingThis trial is testing whether an experimental mRNA vaccine can safely reduce moderate-to-severe acne in adolescents aged 12 to 17. Participants receive either the vaccine at different dose levels or a placebo, and researchers monitor safety and changes in facial acne lesions. The…
Phase 2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New mRNA vaccine aims to outsmart flu by targeting its hidden parts
Vaccine Not yet recruitingThis Phase 1 trial tests experimental mRNA vaccines designed to protect against many types of influenza A by targeting a stable part of the virus. Healthy adults aged 18 to 59 receive one or two doses of the vaccine candidates, alone or in combination. The study checks for side e…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New Self-Amplifying mRNA vaccine aims to better protect transplant patients against COVID-19
Vaccine Not yet recruitingThis study tests a new COVID-19 vaccine (LUNAR-COV19) in 56 adults who received a blood stem cell transplant within the past year. These patients often have weaker immune responses to standard vaccines. The new vaccine uses a self-amplifying mRNA that may produce a stronger and l…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Vaccine
Last updated Sep 19, 2026 00:00 UTC
-
Can a common virus be turned into a TB vaccine? scientists test VIR-1778
Vaccine Not yet recruitingResearchers are testing an experimental tuberculosis vaccine called VIR-1778 in healthy adults who do not have HIV. The vaccine uses a weakened form of human cytomegalovirus to deliver seven TB proteins to the immune system. The trial aims to see if VIR-1778 is safe and whether i…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 16, 2026 00:00 UTC
-
Surgeons could freeze lung tumors from miles away using 5G robots
Disease control Not yet recruitingResearchers are testing whether a doctor can remotely steer a robotic bronchoscope over a 5G network to freeze small lung tumors from inside the airway. The study enrolls about 15 adults with non-small cell lung cancer or controlled metastatic lung tumors, each no larger than 3 c…
Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Two-Drug combo tested against aggressive pancreatic cancer
Disease control Not yet recruitingResearchers are testing whether combining albumin-bound paclitaxel with gemcitabine helps people with metastatic pancreatic cancer who have not yet received systemic treatment. The study enrolls about 59 adults aged 18 to 75 with confirmed metastatic pancreatic adenocarcinoma. Pa…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests whether adjusting chemotherapy doses for each patient can improve outcomes after a stem cell transplant for blood cancers caused by a RUNX1 gene mutation. Up to 98 people aged 4 to 70 with these cancers will receive a transplant from a half-matched donor. The goa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New pill aims to outsmart resistant prostate cancer
Disease control Not yet recruitingResearchers are testing a new oral drug called JNJ-101556143 in people with metastatic prostate cancer that has stopped responding to hormone therapy. The trial aims to see if the drug can shrink tumors or make them disappear. About 100 participants will receive the drug, and doc…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Experimental drug duo aims to boost immune attack on tough cancers
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, obrixtamig and ZL-1310, designed to help the immune system fight cancer. It is for adults with advanced small cell lung cancer or other neuroendocrine cancers. The trial has two parts: the first finds a safe dose of the tw…
Phase 1/2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
Disease control Not yet recruitingThis phase 1 trial is testing an experimental drug called ATG-201 in adults with systemic lupus erythematosus, systemic sclerosis, or Sjögren's disease. ATG-201 is designed to bind to specific proteins on immune cells, potentially quieting the overactive immune response that driv…
Phase 1 • Sponsor: Antengene Biologics Limited • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a faster radiation course match the standard one after breast reconstruction?
Disease control Not yet recruitingResearchers compare two radiotherapy schedules for women who had breast reconstruction after mastectomy for breast cancer. One schedule gives larger daily doses over 3 weeks; the other gives smaller daily doses over 5 weeks. The trial checks whether the shorter schedule controls …
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Bispecific antibody combo aims to deepen myeloma responses
Disease control Not yet recruitingResearchers are testing whether CM336, a bispecific antibody that helps the immune system target myeloma cells, works safely and effectively when combined with daratumumab and lenalidomide. The trial enrolls adults aged 18 to 75 with newly diagnosed multiple myeloma who are not p…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can an app plus nicotine gum help hispanic smokers kick the habit?
Disease control Not yet recruitingThis phase III trial will enroll 854 Hispanic adults who smoke and want to quit. Participants will use the iCanQuit smartphone app, which teaches skills to manage cravings and prevent relapse. Half will also receive nicotine replacement therapy (gum, patch, or lozenge) to ease wi…
Phase 3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New drug takes aim at Hard-to-Treat squamous lung cancer
Disease control Not yet recruitingResearchers are testing an experimental drug called 7MW3711 against the standard chemotherapy docetaxel in people with locally advanced or metastatic squamous non-small cell lung cancer. All participants have already received platinum-based chemotherapy and immunotherapy, and the…
Phase 3 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New antibody RC148 takes aim at lung cancer in Head-to-Head phase 3 trial
Disease control Not yet recruitingResearchers are testing whether adding the experimental drug RC148 to platinum-based chemotherapy helps people with advanced non-squamous non-small cell lung cancer live longer without their disease worsening, compared with tislelizumab plus the same chemotherapy. The trial enrol…
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Triple drug combo targets myeloma that came back
Disease control Not yet recruitingResearchers are testing a combination of three drugs, belantamab mafodotin, cevostamab, and pomalidomide, in adults whose multiple myeloma has returned after at least two prior treatments. The phase 1b trial aims to find the best dose and see how well the combination controls the…
Phase 1 • Sponsor: Canadian Myeloma Research Group • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Engineered immune cells take aim at stubborn solid tumors
Disease control Not yet recruitingThis trial tests a new approach for people with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own myeloid cells, a type of immune cell, which are genetically modified in a lab to produce a cancer-fighting protein called IL…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New antibody drug zuberitamab takes aim at kidney disease in phase 3 trial
Disease control Not yet recruitingResearchers are testing an experimental antibody drug called zuberitamab in people with primary membranous nephropathy, a kidney condition that causes protein to leak into the urine. The trial compares zuberitamab injections with cyclosporine, a standard immune-suppressing drug, …
Phase 3 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a simple bottle help turn the tide on HIV?
Disease control Not yet recruitingThis trial tests whether B-OK bottles, which use beads to visually explain how HIV affects health and how treatment lowers viral load, can help people with HIV stick to their medication. Researchers will roll out the bottles across HIV case management agencies in Philadelphia and…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can an unapproved device change how we manage this condition?
Disease control Not yet recruitingThis trial tests a medical device that has not been approved or cleared by the U.S. FDA. Researchers want to learn whether the device is safe and whether it can help people with a specific condition. Participants receive the device as part of the study, and the team monitors thei…
Phase 4 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can you keep the weight off after stopping GLP-1 drugs? scientists test three exit plans
Disease control Not yet recruitingMany people who lose weight with GLP-1 drugs like semaglutide or tirzepatide face a choice: stay on the drug indefinitely or stop and risk regaining the weight. This pilot trial compares three approaches in 60 adults with obesity who have reached or nearly reached their target we…
Phase 4 • Sponsor: Jing Luo • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a One-Week radiation course match four weeks for prostate cancer?
Disease control Not yet recruitingResearchers are testing whether a five-fraction course of stereotactic body radiotherapy (SBRT) works as well as the standard 20-fraction radiotherapy for men who need radiation after prostate cancer surgery. The trial enrolls 206 adults and randomly assigns them to either the sh…
Phase 3 • Sponsor: Robert Förster • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a targeted drug keep ovarian cancer at bay longer?
Disease control Not yet recruitingThis trial is testing whether a targeted therapy called raludotatug deruxtecan (R-DXd), given alone or with bevacizumab, can help people with newly diagnosed advanced ovarian cancer live longer without their cancer growing. Participants have already completed first-line platinum-…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Four drugs aimed at a leukemia that turns aggressive
Disease control Not yet recruitingResearchers are testing whether a combination of rituximab, pirtobrutinib, lisaftoclax and liposomal mitoxantrone can shrink tumors in adults whose chronic lymphocytic leukemia has transformed into the aggressive cancer Richter syndrome. The trial plans to enroll 23 adults who wi…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can an existing drug boost bevacizumab against recurrent brain cancer?
Disease control Not yet recruitingResearchers are testing whether adding entacapone to bevacizumab is safe and can slow tumor growth in adults with glioblastoma that has returned after standard treatment. The trial enrolls about 96 participants who have not previously received bevacizumab and for whom repeat surg…
Phase 1/2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can targeted drugs boost surgery success in Hard-to-Treat lung cancer?
Disease control Not yet recruitingResearchers are testing whether giving targeted therapy before and after surgery helps people with stage III non-small cell lung cancer that has specific rare gene changes. The study includes 190 adults whose tumors have alterations in genes like EGFR, ALK, ROS1, MET, RET, or KRA…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Could a special supplement boost health in cystic fibrosis?
Disease control Not yet recruitingThis study will test whether a nutrition supplement with different forms of certain nutrients works better than standard supplements for adults with cystic fibrosis. Sixty participants will take the supplement for six weeks, and researchers will measure nutrient levels in their b…
Sponsor: Ohio State University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Triple drug combo targets advanced liver cancer in new trial
Disease control Not yet recruitingResearchers are testing a drug combination for people with advanced hepatocellular carcinoma, a type of liver cancer that cannot be removed by surgery. Participants receive lenvatinib plus tislelizumab, and some also receive gefitinib. The trial compares how long people live with…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a lab-made antibody stop bleeding in a rare blood disorder?
Disease control Not yet recruitingResearchers are testing denecimig, an experimental antibody given as an injection under the skin, in adults newly diagnosed with acquired haemophilia A. This rare condition causes the immune system to attack a clotting protein, leading to sudden and sometimes severe bleeding. The…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can two existing drugs stop rheumatic fever from scarring young hearts?
Disease control Not yet recruitingResearchers are running a Phase 3 trial to see whether hydroxychloroquine or corticosteroids can reduce heart valve damage in children and young people with acute rheumatic fever. The trial enrolls about 600 participants aged 4 to 25 who are hospitalized with confirmed valve infl…
Phase 3 • Sponsor: Starship Child Health, Te Toka Tumai Auckland • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a new pill slow Parkinson's motor decline?
Disease control Not yet recruitingThis phase 2 trial is testing whether an experimental drug called RO7568282 can slow the worsening of motor symptoms in people with early-stage Parkinson's disease. Participants, aged 40 to 85, must be on stable levodopa monotherapy. The study compares the drug against a placebo …
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Could a supplement and drug combo help treat obesity?
Disease control Not yet recruitingThis Phase 2 trial tests whether combining the supplement alpha-lipoic acid with the drug mirabegron can improve how the body processes sugar in people with obesity. Sixty adults aged 18 to 65 with a BMI between 30 and 45 will take the combination or a placebo for 4 weeks. The st…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Liver tumors targeted directly: old pump, new drug
Disease control Not yet recruitingThis trial tests whether a drug called carfilzomib, given directly to the liver through an implanted pump, is safe for people whose colon, adrenal, or bile duct cancer has spread to the liver and persists after prior pump therapy. Participants receive weekly infusions of the drug…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Targeted antibody zolbetuximab tested with chemo against advanced stomach cancer
Disease control Not yet recruitingResearchers are testing whether adding zolbetuximab to standard chemotherapy is safe and helps control advanced stomach or gastroesophageal junction cancer in Indian patients. The trial enrolls 50 adults whose tumors carry the Claudin 18.2 protein but not HER2. Participants recei…
Phase 4 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New team approach aims to simplify care for heart and kidney health
Disease control Not yet recruitingThis study tests a 6-month program where patients work with a pharmacist and their primary care doctor to make shared decisions about medications and lifestyle. The goal is to see if this team-based approach improves heart and kidney health scores and medication adherence. The st…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Experimental drug targets Hard-to-Treat leukemia in small early trial
Disease control Not yet recruitingThis early study tests an experimental drug called zeprumetostat in people with a rare type of leukemia (T-cell large granular lymphocyte leukemia) that has not responded to or has come back after other treatments. Ten participants take the drug twice daily for two 28-day cycles.…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Freezing tumors plus dual immunotherapy: a new attack on bile duct cancer
Disease control Not yet recruitingResearchers are testing whether adding cryoablation, a procedure that freezes tumors, to two drugs can help people with advanced biliary tract cancer that worsened after first-line treatment. The drugs are QL1706, a dual immunotherapy, and lenvatinib, a targeted therapy. The tria…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New injectable drug tested for safety in Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a phase 1 trial of SHR-4595, an experimental injectable drug, in adults with advanced solid tumors that have not responded to standard treatments. The study checks how safe and tolerable the drug is, how the body processes it, and what dose might work best…
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Triple oral drug combo targets two stubborn gynecologic cancers
Disease control Not yet recruitingResearchers are testing a combination of three oral drugs, imlunestrant, abemaciclib, and selinexor, in people with low grade serous ovarian cancer or endometrioid endometrial cancer. The trial enrolls 60 participants in two separate groups, one for each cancer type. Everyone rec…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a vaccine plus a Blood-Vessel blocker stop airway growths from coming back?
Disease control Not yet recruitingThis phase II trial tests whether combining bevacizumab, a drug that limits blood vessel growth, with PRGN-2012, a vaccine-based therapy, can help adults with recurrent respiratory papillomatosis (RRP) avoid needing more surgeries. RRP causes wart-like growths in the airway that …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can two drugs plus chemoradiation let bladder cancer patients keep their bladder?
Disease control Not yet recruitingResearchers are testing whether adding sacituzumab tirumotecan and subcutaneous pembrolizumab to chemoradiotherapy helps people with muscle-invasive bladder cancer live longer without the cancer growing or returning. The trial enrolls about 400 people who have chosen bladder pres…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Targeted drug conjugate CBX-12 tested against childhood sarcomas
Disease control Not yet recruitingResearchers are testing a drug called CBX-12 in children and young adults with solid tumors that have returned or stopped responding to treatment, including rhabdomyosarcoma and Ewing sarcoma. CBX-12 pairs a tumor-seeking peptide with exatecan, a chemotherapy drug that blocks can…
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a biosimilar match vectibix in colorectal cancer treatment?
Disease control Not yet recruitingResearchers are testing whether QL1203, a proposed biosimilar of the drug Vectibix (panitumumab), behaves similarly in the body to the original Vectibix when both are combined with chemotherapy (mFOLFOX6). The trial enrolls adults with RAS wild-type metastatic colorectal cancer t…
Phase 1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingThis study tests two new ways to treat talaromycosis, a serious fungal infection in people with HIV. It compares a single high dose of a newer antifungal drug (liposomal amphotericin B) against two weeks of the standard drug, and also checks if adding another medicine (flucytosin…
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Oral Brain-Penetrating drug tested against aggressive IDH1-Mutant gliomas
Disease control Not yet recruitingResearchers are testing an oral drug called safusidenib in adults newly diagnosed with IDH1-mutant grade 3 oligodendroglioma or astrocytoma, two types of brain tumor. Safusidenib is designed to cross into the brain and block the mutated IDH1 enzyme that drives these tumors. All 2…
Phase 2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
New quadruple therapy targets liver cancer and diabetes together
Disease control Not yet recruitingThis study tests a combination of four drugs (epalrestat, HAIC, donafenib, and tislelizumab) as a first treatment for people with advanced liver cancer that cannot be removed by surgery and who also have diabetes. The goal is to see if this approach can control the cancer for at …
Phase 2 • Sponsor: Haibo Shao • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Diabetes drug dapagliflozin takes on metformin in PCOS hormone battle
Disease control Not yet recruitingResearchers compare dapagliflozin, a diabetes drug, with metformin, the standard insulin-sensitizing treatment, in women with polycystic ovary syndrome. The trial enrolls 70 women aged 18 to 40 who have PCOS and infertility. Over the study, the team measures changes in follicle-s…
Phase 2/3 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a daily pill protect kidneys in IgA nephropathy? MRI study puts atrasentan to the test
Disease control Not yet recruitingResearchers are testing whether adding atrasentan to standard supportive care improves kidney structure and function in adults with IgA nephropathy, a condition where the immune system damages the kidneys. About 20 participants will take atrasentan 0.75 mg once daily for 52 weeks…
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a new pill outsmart Drug-Resistant leukemia?
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called nemtabrutinib in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has stopped responding to other targeted therapies. Participants take nemtabrutinib once daily in 28-day cycles until the …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Hope for sanfilippo kids: Brain-Infused drug enters final testing
Disease control Not yet recruitingThis phase 3 trial tests a drug called tralesinidase alfa in 14 children aged 1-5 with Sanfilippo syndrome type B, a rare genetic disease that causes severe brain damage. The drug is given directly into the brain fluid to replace a missing enzyme. The goal is to see if it can slo…
Phase 3 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Can a Platelet-Boosting drug speed recovery after stem cell transplant?
Disease control Not yet recruitingAfter an allogeneic stem cell transplant, patients often face weeks with dangerously low platelets and need frequent transfusions. This trial tests whether romiplostim, a drug that stimulates platelet production, helps platelets recover faster. Researchers randomly assign 87 adul…
Phase 2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Radioactive drug targets Hard-to-Treat thyroid cancer
Disease control Not yet recruitingThis study tests a radioactive drug called 177Lu-DOTA-EB-TATE in 18 adults with a rare thyroid cancer (Hurthle cell) that has spread and not responded to standard radioactive iodine treatment. The drug is designed to seek out and attach to cancer cells. Participants will receive …
Phase 1/2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 21, 2026 18:00 UTC
-
Triple attack on pancreatic tumors: can radiation and immunotherapy make inoperable cancer operable?
Disease control Not yet recruitingResearchers test whether a short course of targeted radiation followed by the immunotherapy drug adebrelimab and NALIRIFOX chemotherapy can shrink locally advanced pancreatic cancer enough to allow surgery. The trial enrolls 36 adults with previously untreated pancreatic ductal a…
Phase 2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a checklist and heart monitor stop repeat strokes?
Disease control Not yet recruitingResearchers are testing whether an educational and implementation tool helps hospitals follow best-practice guidelines for preventing second strokes caused by heart conditions. The trial enrolls about 2,400 patients who have had an ischemic stroke or a transient ischemic attack. …
Sponsor: Luciano A. Sposato • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sparing the liver: targeted chemoembolization meets lenvatinib in liver cancer
Disease control Not yet recruitingResearchers are testing whether a liver-sparing form of chemoembolization, called partial TACE, can boost the anti-tumor effects of the drug lenvatinib in people with liver cancer that cannot be removed by surgery. The trial enrolls about 40 adults with hepatocellular carcinoma w…
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive missile aims at stubborn kidney tumors
Disease control Not yet recruitingResearchers are testing a radiopharmaceutical called 161Tb-PSMA-1 in adults with metastatic clear cell renal cell carcinoma that has worsened after at least two prior treatments, including immunotherapy and drugs that block blood vessel growth. The trial has two parts: a dose-esc…
Phase 1 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental infusion slow muscle loss in FSHD?
Disease control Not yet recruitingThis trial tests an experimental drug called SFL-0821 in adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. Researchers give the drug by intravenous infusion, either once or multiple times, and compare it agains…
Phase 1/2 • Sponsor: Soufflé Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a daily eye gel replace injections for wet AMD?
Disease control Not yet recruitingThis trial is testing an experimental eye gel called BETA-TT8 for people with wet age-related macular degeneration (AMD), a condition that causes rapid vision loss. The gel is applied to the eye up to three times daily for 12 weeks, and standard injections remain available if nee…
Phase 1/2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can colorectal surgery patients go home in two days?
Disease control Not yet recruitingResearchers are studying whether patients can safely leave the hospital within 48 hours after minimally invasive colorectal surgery. The trial follows 97 adults having elective laparoscopic or robotic surgery for benign or malignant disease. It checks how many meet predefined cli…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two-Drug combo targets stubborn KRAS lung cancer
Disease control Not yet recruitingResearchers are testing whether combining BL-B01D1, an experimental antibody-drug conjugate, with glecirasib, a targeted KRAS G12C inhibitor, can shrink tumors in adults with locally advanced or metastatic non-small cell lung cancer that carries a KRAS G12C mutation. The phase 2 …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly injection melt fat hiding in the pancreas?
Disease control Not yet recruitingThis trial tests whether mazdutide, an experimental weekly injection, can reduce fat buildup in the pancreas of adults with overweight or obesity. About 194 participants will receive either mazdutide or a placebo, alongside standard lifestyle advice, for 48 weeks. Researchers wil…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug combo aims to deepen myeloma response before transplant
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called F182112 to isatuximab and lenalidomide is safe and can help people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The trial enrolls about 10 adults aged 18 to 70. Participants r…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a liposomal drug combo improve AML treatment for older adults?
Disease control Not yet recruitingResearchers are testing a three-drug regimen called VAM for older or unfit adults with newly diagnosed acute myeloid leukemia (AML). The regimen combines liposomal mitoxantrone, azacitidine, and venetoclax. The trial aims to find the safest and most tolerable dose of liposomal mi…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an injected biologic cut steroid Flare-Ups in a Tough-to-Treat asthma complication?
Disease control Not yet recruitingResearchers are studying depemokimab, an injected biologic drug, in adults aged 18 to 75 who have allergic bronchopulmonary aspergillosis (ABPA) along with severe eosinophilic asthma. The study tracks how many asthma attacks need systemic steroids and whether participants' qualit…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can tighter blood pressure control in pregnancy prevent serious complications?
Disease control Not yet recruitingThis trial tests whether treating high blood pressure in pregnancy to a stricter target (below 140/90) is better than the usual approach (below 160/110) for women with gestational hypertension or preeclampsia without severe features. About 4,120 pregnant women will be randomly as…
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug cocktail aims to reverse early heart disease
Disease control Not yet recruitingThis Phase 3 trial will test whether a combination of three cholesterol-lowering drugs—bempedoic acid, ezetimibe, and a high-intensity statin—can reduce and stabilize plaque buildup in the coronary arteries. The study enrolls 103 adults with coronary atherosclerosis who have neve…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat adrenal tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can simple tummy time reshape a Preemie's head?
Disease control Not yet recruitingThis trial tests whether a daily routine of tummy time and careful positioning can help correct cranial asymmetry—a flattened head shape—in premature newborns. About 300 babies born before 37 weeks who are in the neonatal ICU or intermediate care unit will be split into two group…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lab-Grown tumor organoids could pick the right bladder chemo
Disease control Not yet recruitingResearchers are testing whether drug testing in patient-derived organoids can guide chemotherapy for low-grade non-muscle invasive bladder cancer. Adults with primary or recurrent low-grade bladder cancer receive one of four chemo drugs, epirubicin, mitomycin C, gemcitabine, or d…
Phase 2 • Sponsor: Hospital Centre Biel/Bienne • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly shot help people who still struggle with weight after bariatric surgery?
Disease control Not yet recruitingMany people who have bariatric surgery do not lose as much weight as expected or regain it over time. This trial tests whether tirzepatide, a weekly injection that acts on two gut hormones, helps adults with obesity lose more weight after surgery. Participants receive either tirz…
Phase 3 • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a single infusion tame tough lupus?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called SNC116 in people with refractory systemic lupus erythematosus (SLE), a form of lupus that hasn't improved with standard treatments. The study aims to see if a single intravenous infusion of SNC116 is safe and tolerable…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Alpelisib's Long-Term safety tracked in PIK3CA patients
Disease control Not yet recruitingThis study provides continued access to alpelisib for people who are already benefiting from it in a previous Novartis trial. It focuses on tracking long-term safety, including any side effects, in participants with PIK3CA-related overgrowth spectrum or certain breast cancers. Pa…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Patient's own airway stem cells repair damaged lungs in COPD?
Disease control Not yet recruitingResearchers are testing REGEND001, a therapy made from a patient's own airway basal stem cells, to see if it can improve lung function in people with chronic obstructive pulmonary disease (COPD) and emphysema. The trial enrolls adults aged 40 to 75 with moderate to severe COPD. P…
Phase 3 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple checklist help surgeons remove every last cancer cell?
Disease control Not yet recruitingResearchers are testing whether a shared checklist used during lung cancer surgery helps surgeons achieve cleaner, more complete tumor removal. The trial enrolls adults with early-stage non-small cell lung cancer who are scheduled for surgery. Half the participating hospitals use…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New chemo cocktail targets pancreatic cancer at every stage
Disease control Not yet recruitingResearchers are testing a chemotherapy combination built around albumin-bound paclitaxel (II) for people with pancreatic cancer. The study has three groups: one for advanced cancer that cannot be removed by surgery, one for cancer that may be removable and receives treatment befo…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
Disease control Not yet recruitingResearchers are testing a new biological therapy called BI 4060107 in adults with advanced solid tumors that cannot be removed by surgery. The trial is for people who have tried all available treatments and have no other options. The main goal is to find the highest dose that peo…
Phase 1 • Sponsor: AIMEDBIO • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Zapping resistant tumors: could radiation extend the life of current breast cancer therapy?
Disease control Not yet recruitingThis trial is for people with ER-positive, HER2-negative advanced breast cancer whose disease has started to grow in a few spots while on hormone therapy and a CDK4/6 inhibitor. It tests whether adding targeted radiation (SABR) to those spots allows patients to stay on their curr…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can probiotics make h. pylori antibiotics easier on the gut?
Disease control Not yet recruitingResearchers test whether Bacillus probiotics, given alongside standard four-drug antibiotics for H. pylori infection, reduce gut side effects and improve treatment tolerance. The trial enrolls 336 adults with H. pylori who receive either a single-strain probiotic, a multi-strain …
Sponsor: Anabio R&D • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Dual immunotherapy plus chemo before surgery: a new way to shrink stomach tumors?
Disease control Not yet recruitingResearchers are testing whether combining an experimental dual immunotherapy drug called QL1706 with standard chemotherapy (docetaxel, oxaliplatin and S-1) before surgery can help patients with locally advanced gastric or gastroesophageal junction cancer. The study enrolls 34 adu…
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Old antiparasitic drug joins chemo in pancreatic cancer fight
Disease control Not yet recruitingResearchers at the University of Oklahoma are testing whether adding pentamidine, an antiparasitic drug, to standard modified FOLFIRINOX chemotherapy is safe and helps shrink tumors in people with advanced or metastatic pancreatic cancer. Up to 30 adults with confirmed locally ad…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Bacteria-Based immunotherapy targets pancreatic tumors in first human test
Disease control Not yet recruitingResearchers are testing a new immunotherapy called Lm-LLO-TT in adults with advanced pancreatic ductal adenocarcinoma that has already been treated with chemotherapy. Lm-LLO-TT uses a weakened form of Listeria bacteria engineered to carry a tetanus toxoid antigen, aiming to spark…
Phase 1 • Sponsor: Loki Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
A pill instead of surgery? trial tests vepugratinib against Low-Grade bladder cancer
Disease control Not yet recruitingResearchers are testing whether an oral drug called vepugratinib can clear low-grade, intermediate-risk bladder cancer that has not invaded muscle, or low-grade upper tract urothelial cancer. The trial enrolls adults whose tumors carry a specific change in the FGFR3 gene. Partici…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Daily pill giredestrant put to the test for sticking with breast cancer treatment
Disease control Not yet recruitingResearchers are studying giredestrant, an experimental daily pill, in people with estrogen receptor-positive, HER2-negative early breast cancer. The trial enrolls about 1,500 participants, including some who switch to giredestrant after other treatments. It tracks how many people…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Which biologic works best first for ulcerative colitis? major trial aims to find out
Disease control Not yet recruitingThis study compares four different sequences of biologic drugs (infliximab, filgotinib, ustekinumab, and vedolizumab) in 240 adults with moderate to severe ulcerative colitis. The goal is to see which order of treatments works best to achieve and maintain remission without steroi…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Oral drug VT3989 takes on chemo in mesothelioma survival test
Disease control Not yet recruitingResearchers are comparing an experimental oral drug called VT3989 with standard chemotherapy drugs gemcitabine or vinorelbine in adults with advanced epithelioid pleural mesothelioma. All participants have already received platinum-based chemotherapy and immunotherapy, and their …
Phase 3 • Sponsor: Vivace Therapeutics, Inc • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Daily pill takes aim at a rare brain disease that mimics Parkinson's
Disease control Not yet recruitingResearchers are testing an experimental oral drug called ONO-2808 in adults with the Parkinsonian subtype of multiple system atrophy (MSA-P), a rare and progressive brain disorder. The phase 3 trial enrolls about 486 people in the early stages of the disease, within five years of…
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can zapping liver and lung tumors boost treatment for nasopharyngeal cancer?
Disease control Not yet recruitingResearchers are testing whether adding CT-guided thermal ablation of liver or lung metastases to standard systemic therapy improves tumor response in people with nasopharyngeal carcinoma. The trial enrolls 138 adults whose primary tumor was cured but who later developed up to fiv…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gene therapy joins forces with chemo and immunotherapy to fight bladder cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding a gene therapy called nadofaragene firadenovec to standard chemotherapy and immunotherapy can improve outcomes for people with muscle invasive bladder cancer before they have their bladder removed. The gene therapy is placed directly into t…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two oral drugs join chemotherapy in a bid to shrink pancreatic tumors
Disease control Not yet recruitingResearchers are testing whether adding two oral drugs, avutometinib and defactinib, to standard chemotherapy (mFOLFIRINOX) is safe and can slow or shrink pancreatic ductal adenocarcinoma. The trial has two parts: one for people whose cancer has spread, and one for people whose ca…
Phase 1/2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new antibody boost treatment for Hard-to-Treat HER2 breast cancer?
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called HLX22 to standard trastuzumab and chemotherapy helps people with locally advanced or metastatic HER2-positive breast cancer that has already been treated with a HER2 ADC. About 90 adults will receive either HLX22 …
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can antibiotics dripped through the skull bone reach the brain better than IV drugs alone?
Disease control Not yet recruitingResearchers are testing a new way to deliver antibiotics to the brain in people with moderate to severe bacterial meningitis who are not improving on standard intravenous treatment. The approach combines standard IV antibiotics with a continuous infusion of three antibiotics (van…
Sponsor: yilong Wang • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
First-in-Human biologic JUR-003 put to the test against metastatic prostate cancer
Disease control Not yet recruitingResearchers are running a first-in-human Phase 1 trial of JUR-003, an intravenous biologic, in adults with metastatic prostate cancer. The study has two parts: a dose-escalation phase to find the highest dose people can tolerate, and a dose-expansion phase to look at early anti-t…
Phase 1 • Sponsor: Juri Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injectable drug tested against Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a Phase I trial of HEC-921, an experimental drug given by intravenous infusion, in adults with advanced malignant solid tumors. The study first gives HEC-921 alone to find the highest dose people can tolerate, then tests it in combination with oxaliplatin,…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Stem cell infusions put to the test against a tough transplant complication
Disease control Not yet recruitingResearchers are testing whether infusions of bone marrow-derived mesenchymal stem cells, called MesenCell, are safe for adults with moderate or severe chronic graft-versus-host disease that has not responded to steroids and other standard treatments. The trial enrolls up to 20 pe…
Phase 1 • Sponsor: Pontifícia Universidade Católica do Paraná • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New immunotherapy targets genetic flaw in rare childhood cancers
Disease control Not yet recruitingThis study tests a new immunotherapy designed to help the immune system recognize and attack cancer cells in people with high-risk Ewing sarcoma or desmoplastic small round cell tumor (DSRCT). The treatment targets a specific genetic change found only in these cancer cells, aimin…
Phase 1 • Sponsor: Rabi Hanna • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can older women with breast cancer skip chemo? new trial tests CDK4/6 inhibitors
Disease control Not yet recruitingResearchers are testing whether women aged 65 and older with early-stage, lymph node-positive, ER+/HER2- breast cancer can safely skip chemotherapy. Participants receive CDK4/6 inhibitors, with or without endocrine therapy, after surgery. The trial tracks how many women remain fr…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two ways to rebuild a Child's bone: which holds up?
Disease control Not yet recruitingWhen children lose bone to injury, infection, or surgery, doctors can rebuild the limb in different ways. This French study compares two established techniques: the induced membrane method and the vascularized fibula flap, which moves a piece of the calf bone with its blood suppl…
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injection MWN117 tested for safety in obesity
Disease control Not yet recruitingResearchers are testing an experimental drug called MWN117 to see if it is safe and how the body handles it. The trial enrolls 48 healthy and obese Chinese adults who receive a single injection under the skin of either MWN117 or a placebo. Participants are split into groups that …
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Head-to-Head: which JAK inhibitor wins for myelofibrosis patients with low blood counts?
Disease control Not yet recruitingThis study compares two FDA-approved drugs, momelotinib and ruxolitinib, in people with myelofibrosis who also have low blood cell counts. The main goal is to see which drug does a better job at shrinking the spleen and reducing the need for blood transfusions. About 268 particip…
Phase 4 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a diabetes pill help the heart heal after a hole is closed?
Disease control Not yet recruitingAdults with a secundum atrial septal defect (a hole in the heart) who are scheduled for device closure receive either dapagliflozin or a placebo for six months. Researchers use advanced echocardiography to measure how well the right side of the heart recovers and reverses its enl…
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injection for obesity tested for safety in first human trial
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called SHR-1179 in obese adults. The trial aims to see how safe and tolerable a single dose is, and how the body processes the drug. About 50 participants with a body mass index between 28 and 35 will receive either SHR-1179…
Phase 1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Immune-Boosting drug and vaccine aim to fight returning prostate cancer
Disease control Not yet recruitingThis Phase II trial tests whether an immune-boosting drug (N-803) alone or combined with a vaccine (ETBX-071) can lower PSA levels in men whose prostate cancer has returned after targeted radiation therapy. Participants receive up to eight cycles of treatment and are followed for…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two antifungal pills go head to head against a fungus that scars the lungs
Disease control Not yet recruitingResearchers compare two oral antifungal medicines, itraconazole and posaconazole, in people with chronic pulmonary aspergillosis, a fungal infection that damages the lungs over time. The trial enrolls 220 adults who have not yet received antifungal treatment and assigns them to o…
Phase 3 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug put to the test against Hard-to-Treat GI cancers
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called ALK-N001 in adults with advanced gastrointestinal tumors, including esophageal and colorectal cancers that have worsened after standard treatment. The phase II trial gives the drug intravenously every two weeks at one…
Phase 2 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Protein-Guided missiles: can mass spectrometry match the right drug to the right tumor?
Disease control Not yet recruitingResearchers are testing whether measuring specific proteins in tumors can help match patients with advanced pancreatic or breast cancer to antibody-drug conjugates that are more likely to work for them. The trial enrolls 225 adults whose cancer has progressed after prior treatmen…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two-Drug combo takes aim at Hard-to-Treat lung cancer
Disease control Not yet recruitingResearchers are testing whether adding the immunotherapy adebrelimab to HS-20093 (risvutatug rezetecan) works better than HS-20093 alone in adults with advanced or metastatic non-squamous non-small cell lung cancer that has already been treated and has no actionable gene changes.…
Phase 2 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can scans predict which liver cancer patients need extra local therapy?
Disease control Not yet recruitingResearchers are studying whether adding local treatments such as ablation, radiotherapy, or transarterial therapy to the drug combination atezolizumab plus bevacizumab helps certain patients with unresectable hepatocellular carcinoma live longer. The study uses medical records an…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can some children skip the drain after choledochal cyst surgery?
Disease control Not yet recruitingCholedochal cyst is a congenital bile duct problem that surgeons treat by removing the cyst and rebuilding the bile duct with a Roux-en-Y hepaticojejunostomy, often using a surgical robot. Surgeons usually leave an abdominal drainage tube in place afterward, but better robot prec…
Sponsor: Xueqiang Yan • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new biologic slow kidney damage in IgA nephropathy?
Disease control Not yet recruitingThis phase 2 trial is investigating whether an experimental drug called ARGX-121 can improve outcomes for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either ARGX-121 or a placebo, while continuing their usual care. The …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
AI city halls: could Robot-Run domes cure addiction and homelessness?
Disease control Not yet recruitingThis study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will liv…
Sponsor: Veterans Recovery Network Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody pair takes aim at advanced liver cancer in major trial
Disease control Not yet recruitingResearchers are testing whether a new combination of two antibodies, JS207 and JS007, works better than the standard first-line treatment of toripalimab plus bevacizumab for advanced liver cancer. The trial enrolls about 560 adults with liver cancer that cannot be removed by surg…
Phase 3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new drug combo shrink High-Risk throat tumors?
Disease control Not yet recruitingThis phase II trial tests whether the experimental drug BL-B01D1, given with or without a PD-1 antibody, can improve tumor shrinkage in people with high-risk locally advanced nasopharyngeal carcinoma, a type of throat cancer. Participants also receive standard chemotherapy drugs …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a drug combo shrink esophageal tumors before surgery?
Disease control Not yet recruitingResearchers are testing whether giving sacituzumab tirumotecan plus toripalimab before surgery helps people with locally advanced esophageal squamous cell carcinoma. Participants receive three cycles of the combination, then undergo standard surgery to remove the tumor. The main …
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a breast cancer combo be safer for diabetics?
Disease control Not yet recruitingThis trial is testing whether a combination of drugs—inavolisib plus fulvestrant, with or without palbociclib—is safe for people with a specific type of advanced breast cancer (HR+, HER2-negative) that has a PIK3CA mutation, and who also have type 2 diabetes. The main focus is on…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can two drugs spare the bladder in aggressive bladder cancer?
Disease control Not yet recruitingResearchers are testing whether combining enfortumab vedotin and pembrolizumab can shrink muscle-invasive bladder cancer enough to avoid removing the bladder or using radiation. The trial enrolls 25 adults with confirmed muscle-invasive urothelial carcinoma that has not spread. P…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo takes aim at a Hard-to-Treat lung cancer mutation
Disease control Not yet recruitingResearchers are testing whether adding the experimental oral drug HS-10370 to platinum-based chemotherapy, with or without the immunotherapy adebrelimab, works better than tislelizumab plus chemotherapy. The trial enrolls about 448 adults with previously untreated, locally advanc…
Phase 3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
Disease control Not yet recruitingResearchers are running a first-in-human study of MGC030, an antibody-drug conjugate, in people with advanced solid tumors that have come back or stopped responding to standard treatment. The trial includes participants with urothelial, colorectal, gastric, gastroesophageal, esop…
Phase 1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: experimental drug zanzalitinib under study
Disease control Not yet recruitingThis study tests a new drug called zanzalitinib in people with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to soft tissues or organs. The goal is to see if the drug can slow or stop cancer growth. About 19 participants will receive…
Phase 2 • Sponsor: Pedro Barata, MD, MSc • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can zapping residual lung cancer spots extend remission?
Disease control Not yet recruitingResearchers are testing whether adding focused radiation to the few remaining cancer spots helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their disease getting worse. Participants first receive a third-generation EGFR-targeted drug plus plat…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo could shorten histoplasmosis treatment by half
Disease control Not yet recruitingThis study tests if a single high dose of an antifungal drug works better than the standard daily dose for treating moderate to severe histoplasmosis, a serious lung infection. It also compares a newer oral drug to the standard one, and checks if 6 months of treatment is as good …
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a liquid diet calm Crohn's in kids?
Disease control Not yet recruitingResearchers at Assiut University Children Hospital are studying whether a specially prepared medical milk formula called Modulen IBD can bring Crohn's disease into remission and keep it there in children and teenagers. About 40 young patients with mild to moderate active Crohn's …
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new pill ease muscle weakness in myositis?
Disease control Not yet recruitingThis phase III trial tests whether the oral drug nerandomilast can improve symptoms of idiopathic inflammatory myopathies, a group of rare autoimmune diseases that cause muscle weakness and inflammation. Adults with active myositis are randomly assigned to take nerandomilast or a…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Antibody-Drug conjugate takes aim at c-Met-High lung cancer
Disease control Not yet recruitingResearchers are testing whether an experimental drug called telisotuzumab adizutecan works better than standard chemotherapy for people with non-squamous non-small cell lung cancer that has grown after earlier treatment. The trial enrolls about 660 participants whose tumors are E…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to cut pneumonia risk in HIV patients with smart medication checks
Disease control Not yet recruitingThis study tests whether a pharmacist-led electronic consultation can improve lung health for people with HIV who smoke or use certain medications that raise pneumonia risk. Pharmacists will review records and suggest changes like smoking cessation aids, vaccines, or stopping unn…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a Chest-Tube enzyme cocktail clear TB lung fluid?
Disease control Not yet recruitingResearchers at a Malaysian hospital reviewed ten years of records for 160 adults who received intrapleural fibrinolytic therapy, a mix of alteplase and DNase delivered through a chest tube, for complicated pleural infection. The study compares how well the treatment cleared fluid…
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a targeted drug delivery system shrink lung tumors?
Disease control Not yet recruitingThis trial tests an experimental drug called TUB-040 in adults with advanced non-small cell lung cancer that cannot be removed with surgery or has spread. TUB-040 is designed to attach to a protein on cancer cells and deliver a toxic payload directly to the tumor, potentially kil…
Phase 2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Fasting-Mimicking diet tested to protect aging brains
Disease control Not yet recruitingThis study tests whether a special low-calorie, plant-based diet taken for 5 days each month can safely improve blood flow to the brain in middle-aged adults who carry the APOE4 gene, which raises Alzheimer's risk. Forty participants aged 45-65 will be randomly assigned to either…
Phase 1/2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
One operation for cataract and glaucoma? eye surgeons test a Two-in-One approach
Disease control Not yet recruitingResearchers at Assiut University are studying whether combining cataract surgery with a procedure called goniotomy safely lowers eye pressure and reduces the need for glaucoma medications. The trial enrolls 70 adults with cataract plus either primary open-angle or primary angle-c…
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can early symptom relief predict who stays on IBD biologic?
Disease control Not yet recruitingResearchers are tracking how long adults with moderate to severe Crohn's disease or ulcerative colitis keep taking guselkumab, a biologic drug, in routine care. The study follows about 400 people who start the treatment and records when they stop. It also checks whether early imp…
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Iron and folic acid: a simple pill that could ease anemia and heart symptoms?
Disease control Not yet recruitingThis observational study is looking at whether Ferretab comp., an oral iron and folic acid supplement, can improve anemia and heart-related symptoms in adults who also have coronary artery disease or heart failure. Participants take the supplement for 12 weeks as part of their us…
Sponsor: Alcea • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a targeted pill be safely used for RET-Driven cancers in india?
Disease control Not yet recruitingResearchers are studying the safety of selpercatinib, an oral drug, in people in India with advanced cancers that have changes in the RET gene. The trial includes adults with RET fusion-positive non-small cell lung cancer and adults and children aged 12 and older with RET-mutant …
Phase 4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can Pre-Surgery chemo boost outcomes in High-Risk Soft-Tissue sarcoma?
Disease control Not yet recruitingThis phase 3 trial compares adding doxorubicin and ifosfamide (AIM chemotherapy) before standard treatment with pembrolizumab, radiation therapy, and surgery versus standard treatment alone in patients with high-risk soft-tissue sarcomas that can be removed by surgery. Participan…
Phase 3 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Two-Drug combo targets Hard-to-Treat recurrent small cell lung cancer
Disease control Not yet recruitingResearchers are testing a combination of paclitaxel polymeric micelles and ivonescimab in adults with small cell lung cancer that has returned or stopped responding after platinum-based chemotherapy and anti-PD-1/PD-L1 therapy. The phase 2 trial aims to see how many participants'…
Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a 9-Hour eating window reset blood sugar and body rhythms?
Disease control Not yet recruitingResearchers are testing whether limiting all meals and snacks to a 9-hour window each day improves blood sugar control, insulin levels, and daily metabolic rhythms in adults with obesity and prediabetes. The trial enrolls 26 people aged 35 to 75 who usually eat over 13 hours a da…
Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can tailored antibiotic doses beat resistance in the sickest patients?
Disease control Not yet recruitingCritically ill patients on breathing machines often get hospital-acquired lung infections. This trial tests whether adjusting antibiotic doses using drug level monitoring and software works better than standard dosing. About 610 adults in intensive care units will receive either …
Sponsor: The University of Queensland • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug BL-M08D1 joins standard therapy in fight against aggressive lymphoma
Disease control Not yet recruitingResearchers are testing an experimental drug called BL-M08D1 alongside standard immunochemotherapy in adults with diffuse large B-cell lymphoma. The trial enrolls about 204 people aged 18 to 75 whose cancer has at least one measurable lesion. Participants receive BL-M08D1 plus a …
Phase 1/2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Triple attack on aggressive sarcoma: can radiation, immunotherapy, and chemo shrink tumors before surgery?
Disease control Not yet recruitingThis phase 2 trial tests a three-part treatment for people with high-risk undifferentiated pleomorphic sarcoma (UPS), a rare cancer of soft tissue. Participants receive focused radiation (SBRT), the immunotherapy drug toripalimab, and a lower dose of the chemotherapy drug liposom…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Antibody-Drug conjugate takes aim at relapsed ovarian cancer
Disease control Not yet recruitingResearchers are testing whether torvutatug samrotecan, alone or with bevacizumab, works better than standard care as maintenance therapy for people with platinum-sensitive relapsed ovarian, fallopian tube, or primary peritoneal cancer. The trial enrolls about 600 participants who…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
One eye injection, four targets: GenSci148 tested against retinal swelling
Disease control Not yet recruitingResearchers are testing an experimental eye injection called GenSci148 in people with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). GenSci148 is a fusion protein designed to block four proteins involved in blo…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Radiation and immunotherapy combo tested against advanced lung cancer
Disease control Not yet recruitingResearchers are testing whether adding stereotactic radiation to two drugs, envafolimab and endostar, helps people with stage IV non-small cell lung cancer. Participants have tumors without common EGFR, ALK, or ROS1 mutations and have not received prior systemic treatment. Everyo…
Phase 2 • Sponsor: The First People's Hospital of Lianyungang • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can shedding pounds stop atrial fibrillation in its tracks?
Disease control Not yet recruitingResearchers in Denmark are testing whether a structured weight loss program can slow the progression of atrial fibrillation in people who are overweight or obese. The trial enrolls 480 adults with symptomatic paroxysmal or early persistent atrial fibrillation and a body mass inde…
Sponsor: Axel Brandes • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a new drug combo reach lymphoma hiding in the brain?
Disease control Not yet recruitingResearchers are testing whether adding pirtobrutinib to methotrexate and standard chemoimmunotherapy can help people with diffuse large B-cell lymphoma that has spread to the central nervous system. The trial enrolls about 24 people aged 14 to 80 whose lymphoma involves the brain…
Phase 2 • Sponsor: Pengpeng Xu • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Cataract lens under the microscope: does it stay put?
Disease control Not yet recruitingResearchers are studying how stable the RayOne RAO800S intraocular lens is after cataract surgery. The lens replaces the eye's cloudy natural lens and has marks to help surgeons position it. Adults scheduled for cataract surgery in both eyes receive the lens as part of routine ca…
Sponsor: Rayner Intraocular Lenses Limited • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a pill replace the liquid? testing a new form of cystic fibrosis drug
Disease control Not yet recruitingResearchers are testing whether a tablet form of the experimental cystic fibrosis drug VX-581 gets into the bloodstream as well as the liquid form. Sixteen healthy adults will take both forms in a randomized order, and researchers will measure drug levels in their blood over time…
Phase 1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a new drug combo keep ovarian cancer from coming back?
Disease control Not yet recruitingThis phase 3 trial tests whether adding an experimental drug called BG-C9074 to bevacizumab helps adults with epithelial ovarian, fallopian tube, or primary peritoneal cancer whose disease has not worsened after initial platinum-based chemotherapy plus bevacizumab. Participants r…
Phase 3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a migraine drug make oral cancer treatment hit harder?
Disease control Not yet recruitingResearchers are testing whether adding rimegepant to standard chemoimmunotherapy before surgery helps shrink oral or oropharyngeal squamous cell carcinoma more effectively. The trial enrolls adults with primary or recurrent disease who are scheduled for surgery. Participants rece…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Immunotherapy added to chemo aims to boost cervical cancer remission
Disease control Not yet recruitingResearchers are testing whether adding the immunotherapy drug adebrelimab to standard chemotherapy before and after surgery can improve outcomes for people with locally advanced cervical cancer. About 35 participants will receive three cycles of adebrelimab plus paclitaxel and ci…
Phase 2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a stronger radiation dose fix hormone overload?
Disease control Not yet recruitingResearchers are testing whether a higher dose of proton beam therapy can normalise hormone levels better than standard radiotherapy in people with functioning pituitary tumours, including acromegaly and Cushing's disease. Participants receive about six weeks of either standard-do…
Phase 3 • Sponsor: University College, London • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug SKB571 tested against deadly pancreatic cancer
Disease control Not yet recruitingResearchers are testing an investigational drug called SKB571 in adults with advanced or metastatic pancreatic cancer. The trial aims to see how well the drug shrinks tumors and how safe it is. Participants receive SKB571 every three weeks, and doctors track their response using …
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can an oral drug that starves tumors help Hard-to-Treat cancers?
Disease control Not yet recruitingResearchers are testing an investigational oral drug called catequentinib hydrochloride (AL3818) in adults with advanced or metastatic endometrial cancer, low grade serous ovarian cancer, soft tissue sarcoma, or glioblastoma. The trial has two parts: a phase 1b part to find safe …
Phase 1/2 • Sponsor: Advenchen Pharmaceuticals, LLC. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Targeted drug 3D185 put to the test against FGFR2-Altered bile duct cancer
Disease control Not yet recruitingResearchers are testing a drug called 3D185 in people with advanced or metastatic cholangiocarcinoma, a type of bile duct cancer, whose tumors have changes in the FGFR2 gene. All participants have already received at least one other systemic cancer treatment that stopped working.…
Phase 2 • Sponsor: 3D Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can pairing immunotherapy drugs shrink Hard-to-Treat skin cancers?
Disease control Not yet recruitingResearchers are testing the drug cemiplimab, given alone or with other anti-cancer drugs, in people with locally advanced basal cell carcinoma that cannot be treated with surgery or radiation. The trial compares how well the combinations work against cemiplimab by itself and trac…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Precision radiation aims a second strike at prostate Cancer's return
Disease control Not yet recruitingResearchers test whether a short, highly focused course of stereotactic body radiotherapy can safely treat prostate cancer that has come back in one small area after earlier radiation. The study enrolls 60 men under 80 whose cancer returned locally and who have not yet started ho…
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
A new pill for obesity? early human trial puts HRS-1597 to the test
Disease control Not yet recruitingResearchers are running a Phase 1 trial of HRS-1597, an experimental tablet for obesity and metabolic disorders. The study gives single doses to healthy volunteers and multiple doses to obese participants to check safety, tolerability, and how the drug moves through the body. It …
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Bile may hold the key to guiding targeted treatment for bile duct and gallbladder cancers
Diagnosis Not yet recruitingResearchers want to know whether leftover bile fluid can reveal genetic changes in tumors of people with advanced biliary tract cancer, such as bile duct or gallbladder cancer. Collecting tumor tissue for genetic testing can be difficult or risky in this cancer, so the study coll…
Sponsor: CHA University • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Can a Tumor's DNA reveal the best lymphoma treatment?
Diagnosis Not yet recruitingResearchers at M.D. Anderson Cancer Center are testing whether comprehensive genomic sequencing can identify specific subtypes of large B-cell lymphoma and provide information that may help guide treatment decisions. The trial enrolls about 60 adults with stage 3 or 4 diffuse lar…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
New PET tracer targets ACP3 to spot prostate cancer
Diagnosis Not yet recruitingResearchers are testing a new PET imaging agent called [68Ga]Ga-OncoACP3 that targets a protein called ACP3, which is found in prostate cancer cells. The study enrolls 50 men with suspected or confirmed high-risk prostate cancer, or suspected recurrence after treatment. Each part…
Phase 2 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Can two blood markers catch sepsis before it turns deadly?
Diagnosis Not yet recruitingSepsis is hard to spot early because its first symptoms look like many other conditions. Researchers at emergency departments in Taiwan are studying whether two blood markers, presepsin and immature granulocytes, can help doctors tell sepsis apart from other causes of inflammatio…
Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Can AI make lung cancer scans easier to read?
Diagnosis Not yet recruitingResearchers are building an artificial intelligence system that analyzes chest CT images and offers decision support to doctors reading those scans for lung cancer. They use deidentified CT exams from routine care to develop and lock the AI models. In the prospective stage, about…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 21, 2026 18:00 UTC
-
Your phone as a stethoscope: can an app spot hidden heart valve disease?
Diagnosis Not yet recruitingResearchers are testing whether a smartphone app called Stethophone can help primary care doctors find moderate or severe aortic stenosis in adults aged 70 and older. The app turns a phone into a digital stethoscope and analyzes heart sounds for murmurs that may signal the condit…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New PET tracer aims to light up hidden cancer targets
Diagnosis Not yet recruitingResearchers are testing a new PET/CT imaging tracer called [68Ga]-LY4257529 that targets a protein called GRPR, which some cancers make in large amounts. The study includes up to 60 adults with breast cancer or other tumors known or suspected to express GRPR, such as prostate, ov…
Early phase 1 • Sponsor: Jewish General Hospital • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a blood test before pancreatic surgery predict a dangerous leak?
Diagnosis Not yet recruitingResearchers are studying whether immune markers in a blood sample taken before pancreatic cancer surgery can predict a serious complication called postoperative pancreatic fistula, where digestive fluids leak from the surgical connection. Adults scheduled for curative-intent panc…
Sponsor: Institut Paoli-Calmettes • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can 'Queen Mothers' bring HIV testing to the doorstep?
Diagnosis Not yet recruitingResearchers are testing whether sex work managers, called queen mothers, can hand out and collect HIV self-tests and self-collected STI test kits at places where female sex workers meet and work in Lusaka. The study compares this peer-supported approach with the current standard …
Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
App aims to catch a hidden radiotherapy side effect
Diagnosis Not yet recruitingRadiation pneumonitis is a lung inflammation that can appear weeks after radiotherapy for lung cancer, and patients may not link their symptoms to the earlier treatment. Researchers developed a smartphone app called PneumoCheck for patients to use at home, hoping it helps detect …
Sponsor: University Hospital Schleswig-Holstein • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
A 2.2 mm scope could spot cancerous tissue in minutes, not days
Diagnosis Not yet recruitingDoctors usually send colorectal tissue to a lab and wait days for results. This pilot study tests a miniaturized device called MULTISCOPE that uses light-based imaging to tell healthy tissue from cancerous tissue in real time. Researchers will examine 30 tissue samples removed du…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Mapping the DNA test that decides who gets PARP inhibitors
Diagnosis Not yet recruitingResearchers are reviewing medical records from about 1,125 women in Italy with newly diagnosed advanced high-grade epithelial ovarian cancer. The study focuses on how hospitals test tumors for homologous recombination deficiency (HRD), a DNA repair flaw that can make PARP inhibit…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI helps surgeons see brain tumors better during surgery
Diagnosis Not yet recruitingThis trial tests a new AI device that helps surgeons see brain tumors on ultrasound images during surgery. The AI highlights tumor tissue in real time, which may help remove more of the tumor while protecting healthy brain. The study involves 100 adults scheduled for brain tumor …
Phase 3 • Sponsor: Hospital del Rio Hortega • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
New blood test method for liver disease could make diagnosis easier
Diagnosis Not yet recruitingThis study checks if a simpler way to collect blood samples works as well as the standard method for the HepQuant DuO liver test. The test involves drinking a natural substance and taking blood samples 20 and 60 minutes later. Researchers will compare different blood collection t…
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Breath test aims to classify leukaemia in hours, not days
Diagnosis Not yet recruitingDoctors often wait days for genetic tests to classify acute myeloid leukaemia (AML) and guide treatment. This trial tests whether breath analysis can detect metabolic products from leukaemia and classify the disease faster. Participants give breath samples and extra blood tests d…
Sponsor: Jeremy Deuel • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a glowing dye show surgeons where head and neck tumors end?
Diagnosis Not yet recruitingResearchers at Washington University School of Medicine are studying whether a fluorescent dye called indocyanine green can help visualize the edges of head and neck squamous cell carcinoma during surgery. The study plans to enroll 25 adults who are having surgery for confirmed o…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Could a week of acid drugs double as a GERD test?
Diagnosis Not yet recruitingResearchers are testing whether early symptom relief from tegoprazan can help diagnose gastroesophageal reflux disease (GERD). Adults with frequent heartburn or acid regurgitation take tegoprazan or a placebo once daily for one week. By comparing symptom improvement between the g…
Phase 4 • Sponsor: HK inno.N Corporation • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
DNA test for infections: can it guide antibiotic decisions?
Diagnosis Not yet recruitingResearchers are running a large observational registry to see how a blood test called metagenomic sequencing is used in routine care for people with or at risk of serious infections, including those with weakened immune systems. The study enrolls participants at multiple hospital…
Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI boosts colonoscopy accuracy in massive new trial
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) system can help doctors spot more precancerous polyps and colorectal cancers during colonoscopy compared to standard procedures. Over 3,300 adults scheduled for screening or surveillance will be randomly assigned to AI-assi…
Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a fetal heart ultrasound index predict trouble in High-Risk pregnancies?
Diagnosis Not yet recruitingResearchers at Assiut University are studying whether two ultrasound measures of fetal heart function and blood flow can predict poor outcomes in pregnancies complicated by diabetes or preeclampsia. The study enrolls 69 pregnant women, including those with gestational diabetes, p…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Software aims to steer bronchoscopes more precisely in lung cancer checks
Diagnosis Not yet recruitingResearchers at Penn State University are testing three software innovations designed to improve bronchoscopy guidance during lung cancer evaluations. The study enrolls a small number of adults who are already scheduled for a clinical bronchoscopy to examine abnormal lung tissue o…
Sponsor: Penn State University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Hidden viruses in Kids' noses may raise surgery breathing risks
Diagnosis Not yet recruitingResearchers swab the noses of children scheduled for elective surgery under general anesthesia to check for respiratory viruses. They want to learn how many children carry viruses without showing symptoms and whether those children have more breathing problems during or after sur…
Sponsor: Brittany Willer • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Can a computer model speed up sepsis blood tests?
Diagnosis Not yet recruitingResearchers are building a web-based simulation platform to model how long blood cultures take from collection to result reporting in sepsis cases. The study involves microbiological laboratories that perform blood culture analysis. The goal is to understand how lab infrastructur…
Sponsor: University Medicine Greifswald • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Turkish Parkinson's dementia test put under the microscope
Diagnosis Not yet recruitingResearchers are checking whether a Turkish translation of the Parkinson Neuropsychometric Dementia Assessment (PANDA) gives consistent and accurate results in people with Parkinson's disease. About 100 Turkish-speaking patients will complete the questionnaire, which tests memory,…
Sponsor: Acibadem University • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Blood test maps hidden resistance signal in advanced breast cancer
Diagnosis Not yet recruitingPeople with hormone receptor-positive, HER2-negative advanced breast cancer often start treatment with a CDK4/6 inhibitor plus an aromatase inhibitor. Over time, some tumors develop an ESR1 mutation that can make the aromatase inhibitor stop working. This study takes blood sample…
Sponsor: Institut fuer Frauengesundheit • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
New brush device aims to improve pancreatic cyst diagnosis
Diagnosis Not yet recruitingResearchers test a new endoscopic device called the loop brush fine needle aspiration (lbFNA) to sample pancreatic cysts in people scheduled for surgery. The pilot study enrolls 8 adults with cysts that require surgical removal. Doctors use the device to puncture, brush, and aspi…
Sponsor: Urban Arnelo • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI learns to measure bowel inflammation from ultrasound
Diagnosis Not yet recruitingResearchers at the University of British Columbia are collecting intestinal ultrasound images from adults, including healthy people and those with inflammatory bowel disease such as Crohn disease or ulcerative colitis. The goal is to build a computer program that can measure bowe…
Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Sauna test aims to measure sweat loss in rare ROSAH syndrome
Diagnosis Not yet recruitingResearchers are testing a new way to measure how much sweat the body produces during controlled heat exposure. About 20 healthy volunteers and up to 10 people with ROSAH syndrome, a rare genetic condition that can cause reduced sweating, will sit in a temperature-controlled sauna…
Sponsor: The Third Xiangya Hospital of Central South University • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI turns routine chest scans into breast cancer detector
Diagnosis Not yet recruitingResearchers are testing whether an artificial intelligence model can spot breast cancer on chest CT scans that women already receive during routine health exams. The study includes a retrospective phase to validate the AI on existing images and a prospective phase where the AI re…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
New MRI techniques could spare men from unnecessary prostate biopsies
Diagnosis Not yet recruitingResearchers are testing three advanced diffusion MRI sequences to see which one best identifies men who can safely skip a prostate biopsy. The study includes men with suspicious prostate MRI results and those already scheduled for a routine MRI. By comparing these new scans again…
Sponsor: University College, London • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Can a CBD-Based drug stop seizures before they start?
Prevention Not yet recruitingThis trial tests whether Epidiolex, a prescription CBD medication, can delay or prevent the first seizure in infants with Sturge-Weber syndrome, a rare condition that often leads to seizures and developmental challenges. The study enrolls babies aged 1 to 18 months who have brain…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Flu shot showdown: can anflu match vaxigrip in Moms-to-Be?
Prevention Not yet recruitingResearchers are testing whether Sinovac's Anflu flu vaccine produces a strong immune response in pregnant women compared with Sanofi's Vaxigrip. The trial enrolls 150 healthy pregnant women between 22 and 34 weeks of pregnancy. Each participant receives one dose of either vaccine…
Phase 4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Can an app help black teens stay HIV-Free? small study aims to find out
Prevention Not yet recruitingThis study will test a mobile app called HealthMPowerment designed to help Black adolescents and young adults in Alabama take PrEP, a daily pill that prevents HIV. Ten teens and their adult supporters will use the app for a few weeks, and researchers will check if it's easy and a…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Can a stearic Acid-Rich diet improve blood vessel health?
Prevention Not yet recruitingResearchers are testing whether a diet high in stearic acid, a type of saturated fat found in cocoa butter, improves blood vessel function compared with a diet high in oleic acid, the main fat in olive and canola oils. The trial enrolls 40 overweight or obese adults aged 40 to 70…
Sponsor: Florida State University • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Can a drug combo stop esophageal cancer from returning after surgery?
Prevention Not yet recruitingResearchers are testing whether giving an anti-PD-1 immunotherapy drug together with anlotinib after surgery can prevent or delay the return of esophageal squamous cell carcinoma. The trial enrolls adults aged 18 to 75 who had chemotherapy plus immunotherapy before surgery, then …
Phase 2 • Sponsor: Shanghai Chest Hospital • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
School-Based digital tool aims to curb childhood obesity in beijing
Prevention Not yet recruitingThis study tests a school-based weight management program using a WeChat digital platform to help children in Fangshan District, Beijing, avoid excessive weight gain. About 1,400 children in grades 2 and 3 will either receive the program (health classes, daily physical activity, …
Sponsor: Peking University • Aim: Prevention
Last updated Sep 21, 2026 18:00 UTC
-
Can a common steroid shield breast cancer patients from a dangerous drug side effect?
Prevention Not yet recruitingTrastuzumab deruxtecan (T-DXd) treats metastatic breast cancer but can cause interstitial lung disease (ILD), a form of lung inflammation that sometimes forces patients to stop treatment. Researchers are testing whether giving dexamethasone before each T-DXd infusion lowers the c…
Phase 3 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a pharmacist chat group help stop HIV?
Prevention Not yet recruitingResearchers at the University of Washington are studying whether an online community of practice helps pharmacists learn to prescribe PrEP, a daily pill that prevents HIV. The study enrolls about 500 pharmacists and pharmacy staff across the United States whose pharmacies do not …
Sponsor: University of Washington • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a mobile app plus a breast model teach women to fight cancer fatalism?
Prevention Not yet recruitingResearchers test a hybrid breast cancer education program for women aged 20 to 65 who visit an obstetrics and gynecology clinic. The program combines a face-to-face session using a breast model with four weeks of educational messages and reminders sent through a mobile app. The t…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
One dose to block the flu: baloxavir put to the test in households
Prevention Not yet recruitingResearchers are testing whether a single dose of the antiviral drug baloxavir marboxil can stop influenza from spreading among people who live with someone who has the flu. The trial enrolls households in China where one person has confirmed influenza and up to five other members…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
How long does RSV protection last in a Baby's nose?
Prevention Not yet recruitingClesrovimab is an FDA-approved antibody shot for infants under 8 months entering their first RSV season when their mothers did not get an RSV vaccine in pregnancy. Researchers at Emory University are measuring antibody levels in the blood and noses of 24 healthy infants who recei…
Phase 4 • Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingThis study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…
Phase 1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can an AI chatbot coach people away from type 2 diabetes?
Prevention Not yet recruitingResearchers are testing an AI chatbot that gives personalized, culturally tailored advice on nutrition, physical activity, and goal setting to adults at risk for type 2 diabetes. About 30 adults aged 18 to 55 will use the chatbot for 6 weeks. The study will check whether the chat…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can AI protect Kids' eyesight where eye doctors are scarce?
Prevention Not yet recruitingResearchers are testing whether an artificial intelligence tool can sort children by their risk of nearsightedness and guide personalized prevention, such as more outdoor time and special glasses. The trial enrolls about 1,600 students in grades 1 through 3 from public primary sc…
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can one visit cover HPV and tetanus protection? a phase 3 trial puts the question to the test
Prevention Not yet recruitingResearchers are testing whether a quadrivalent HPV vaccine can be given at the same time as a tetanus-diphtheria booster in healthy children and adolescents aged 9 to 15 in Indonesia. The trial compares children who receive both vaccines together with those who receive the HPV va…
Phase 3 • Sponsor: PT Bio Farma • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Nepal trial tests community program to prevent lung disease
Prevention Not yet recruitingThis study tests whether a program led by community health workers can improve lung health for 800 people in Bhaktapur, Nepal, who are at risk for chronic respiratory diseases. The program includes tobacco cessation counseling, mask use during high pollution, handwashing, and flu…
Phase 4 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Tiny tweets, big impact? testing digital nudges to boost HIV prevention
Prevention Not yet recruitingResearchers at Emory University are running a rapid randomized controlled trial to see if small changes to digital messages and website design can help more people start and stay on HIV prevention medication (PrEP) through telehealth. The study includes adults in the United State…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a new drug wipe out hidden cancer DNA and stop colorectal cancer from returning?
Prevention Not yet recruitingResearchers are testing an experimental drug called INCA33890 in people with stage II or III colorectal cancer who have finished surgery and chemotherapy but still have tiny amounts of tumor DNA in their blood. This leftover DNA, called circulating tumor DNA or ctDNA, can signal …
Phase 2 • Sponsor: Incyte Corporation • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
A 10-Minute chat in the Doctor's office could teach teens to save a life
Prevention Not yet recruitingThis trial tests whether a short educational session during a routine primary care visit can help young people aged 13 to 26 understand overdose risks, recognize an overdose, and respond with naloxone. Providers in the intervention group deliver the education and offer naloxone a…
Sponsor: Boston Medical Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Double probe heat therapy may slash cervical cancer risk in HIV-positive women
Prevention Not yet recruitingThis study will test if using two heat probes instead of one can better prevent cervical cancer in 300 women with HIV in Zimbabwe. The standard single-probe treatment often fails in these women. The goal is to see if the two-probe method is safe, acceptable, and more effective at…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
New injectable HIV prevention drug tested in healthy volunteers
Prevention Not yet recruitingResearchers are testing a new injectable drug called VH5356136 to see if it is safe and how the body processes it. The trial enrolls about 160 healthy adults without HIV, ages 18 to 55. Participants receive a single dose of the drug or a placebo, and researchers monitor side effe…
Phase 1 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
A digital coach may guide patients through cervical cancer prevention
Prevention Not yet recruitingThis trial tests whether an animated health coach on a smartphone can help people who have abnormal cervical cancer screening results get the follow-up care they need. Many people skip these appointments, which can lead to preventable cancer. The study will enroll 750 adults aged…
Sponsor: Tufts Medical Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a Choose-Your-Own-Adventure comic help kids eat better and move more?
Prevention Not yet recruitingResearchers at Tufts University are testing whether an interactive, customizable digital comic can help Black and Latino children ages 8 to 12 develop healthier eating and physical activity habits. The comic lets children make choices that change the story and health messages the…
Sponsor: Tufts University • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
New injectable HIV prevention candidate tested for safety
Prevention Not yet recruitingResearchers are testing an experimental injectable drug called VH4367310 in healthy adults aged 18 to 55. The drug is a long-acting form of cabotegravir, a medicine already used to prevent HIV. This phase 1 trial gives a single increasing dose to measure how the body processes th…
Phase 1 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
An animated video takes aim at missed lung cancer screening
Prevention Not yet recruitingResearchers at Johns Hopkins University are testing whether a short animated video and brochure, sometimes followed by a phone call, can help people at higher risk of lung cancer get low-dose CT screening. The trial enrolls adults aged 50 to 80 with a significant smoking history …
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Can a tablet app get more kids vaccinated against Cancer-Causing HPV?
Prevention Not yet recruitingHPV vaccines can prevent thousands of cancer cases each year, but many children do not get them. Researchers at the University of Florida test whether a tablet app called Protect Me 4 helps parents and doctors talk about the vaccine and decide to give it. The trial enrolls parent…
Sponsor: University of Florida • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
One extra therapy session may keep cancer patients off cigarettes
Prevention Not yet recruitingResearchers at Vietnam National Cancer Hospital are testing whether adding one structured cognitive behavioral therapy (CBT) session to standard brief counseling helps cancer patients remain smoke-free. The trial enrolls 498 adults who smoked at cancer diagnosis and have stayed c…
Sponsor: Vietnam National Cancer Hospital • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Two diabetes drugs face off to shield hearts during breast cancer chemo
Prevention Not yet recruitingDoxorubicin is a common chemotherapy for breast cancer, but it can damage the heart. This trial compares two diabetes drugs, empagliflozin and metformin, to see if either can protect heart function in women receiving doxorubicin-based treatment. About 150 women with breast cancer…
Phase 3 • Sponsor: Tanta University • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Can a Probiotic-Prebiotic blend stop deadly gut infections in ICU patients?
Prevention Not yet recruitingCritically ill patients on breathing machines often develop dangerous gut bacteria that can lead to hospital-acquired infections. Researchers are testing a synbiotic medical food, a mix of probiotics and prebiotics, to see if it safely reduces these harmful bacteria. The trial en…
Phase 1/2 • Sponsor: University of Calgary • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Can steroids, a migraine drug, or tongue exercises save nerves after throat cancer treatment?
Symptom relief Not yet recruitingPeople treated with radiation for oropharyngeal cancer can later develop damage to cranial nerves, especially the nerve that controls the tongue. This trial tests four approaches to see if they are safe and practical: high-dose prednisone, the injectable drug fremanezumab, a home…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Mindfulness on your phone: a new test for sickle cell pain and sleep
Symptom relief Not yet recruitingThis trial tests whether a smartphone-based mindfulness program can help adolescents and young adults with sickle cell disease manage chronic pain and sleep problems. Participants are randomly assigned to either use the mindfulness app for about 8 weeks or receive usual care. The…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Enzyme pill tested to calm celiac gut symptoms
Symptom relief Not yet recruitingResearchers are testing whether a dietary supplement called Galactol improves overall well-being and reduces gastrointestinal symptoms in adults with celiac disease who have functional abdominal bloating. The study enrolls 50 people aged 18 to 70. Participants take either Galacto…
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Zapping nerves without a scalpel: can radiofrequency quiet chronic pain?
Symptom relief Not yet recruitingResearchers are testing whether a noninvasive device called Hypersound can reduce chronic neuropathic or radicular pain in adults. The system uses external antennas to deliver radiofrequency energy to peripheral nerves without implants or needles. About 71 participants receive te…
Sponsor: Hypersound Medical Inc • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
New foam could offer relief for rare skin bumps
Symptom relief Not yet recruitingThis study tests a medicated foam (AMZEEQ®) on a rare skin condition called CARP, which causes brown, scaly patches. About 35 people aged 9 and older will apply the foam to one side of their body and a plain moisturizer to the other for 5 weeks. The goal is to see if the foam is …
Early phase 1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can a 6-Week online program sharpen everyday thinking?
Symptom relief Not yet recruitingThis pilot study explores whether a personalized telerehabilitation program can help adults who notice cognitive slips in daily life. Participants include older adults and adults with Ehlers-Danlos Syndrome who report subjective cognitive complaints. Over six weeks, they receive …
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab (Keytruda), a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog and dizziness in people with long COVID. Fifteen adults who had COVID-19 at least six months ago and still have…
Phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Could a higher dose of an Alzheimer's drug boost thinking skills in down syndrome?
Symptom relief Not yet recruitingThis early-stage trial will test whether higher-than-standard doses of memantine, a drug already approved for Alzheimer's, are safe and tolerable in 25 adolescents and young adults with Down syndrome. The study also looks for early signs that the drug might improve memory and thi…
Phase 1 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
VR headset may calm kids before heart procedure
Symptom relief Not yet recruitingChildren scheduled for angiography often feel anxious, which can affect their heart rate, blood pressure and cooperation during the procedure. This trial tests whether a short virtual reality guided breathing exercise, delivered through a headset showing calming scenery, can redu…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can a nurse coach couples back to intimacy after prostate cancer?
Symptom relief Not yet recruitingResearchers are testing a six-week, nurse-led program that helps Chinese prostate cancer survivors and their female partners talk about sex, rebuild intimacy, and cope together after treatment. About 72 couples join the study, with half receiving the program plus standard survivo…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Blood-flow cuffs may mimic exercise to ease Parkinson's symptoms
Symptom relief Not yet recruitingThis trial tests whether ischemic conditioning — brief cycles of blood-flow restriction using pressure cuffs on the arms — can improve motor function and cognitive performance in people with Parkinson's disease. Over 12 weeks, 34 participants will receive 24 sessions of the thera…
Sponsor: Hospital Israelita Albert Einstein • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
Symptom relief Not yet recruitingResearchers at Hospital Universitario Austral in Argentina are testing whether a structured three-session music therapy program called MUSPAL360 can be delivered to hospitalized adults with advanced cancer receiving palliative care. The program combines live music therapy with 36…
Sponsor: Austral University, Argentina • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Parkinson's patients may move better with music therapy
Symptom relief Not yet recruitingThis pilot study will test whether active music therapy (with a therapist) or passive music therapy (just listening to music) can improve exercise ability and motivation in 28 people with Parkinson's disease. Participants will do sit-to-stand and walking tests while receiving mus…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Leg cuffs plus walking: a new way to steady Parkinson's balance?
Symptom relief Not yet recruitingPeople with Parkinson's disease often struggle with balance and anxiety, and the two can make each other worse, especially when they try to walk and think at the same time. High-intensity aerobic exercise may help both, but Parkinson's symptoms make it hard for many to reach that…
Sponsor: National Cheng-Kung University Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Two lens designs go Head-to-Head for aging eyes
Symptom relief Not yet recruitingResearchers compare two monthly replacement silicone hydrogel multifocal toric contact lenses in people over 40 who already wear soft contacts. The study measures how easy the lenses are to handle, especially removal, and other performance factors. About 60 participants with asti…
Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can qigong loosen the grip of fibromyalgia? trial tests two styles
Symptom relief Not yet recruitingResearchers are testing whether Qigong, a mind-body exercise, can improve spinal mobility and reduce pain in women with fibromyalgia. The trial randomly assigns 36 women aged 30 to 50 to one of two online Qigong programs: one focused on fluid, mobility-intensive movements, the ot…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can focused electrical fields deep in the brain ease Parkinson's tremors?
Symptom relief Not yet recruitingResearchers at Tongji Hospital are testing a non-invasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in 26 people with Parkinson's disease. The study uses MRI scans to customize electrode placement so the stimulation reaches deep brai…
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Laughter yoga: a surprising cure for nurse burnout?
Symptom relief Not yet recruitingThis study tests whether a structured laughter yoga program can reduce burnout, stress, and compassion fatigue in nurse managers. Eighty nurse managers will either join laughter yoga sessions twice a week for 8 weeks or continue as usual. Researchers will measure changes in stres…
Sponsor: Zonguldak Bulent Ecevit University • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can a Weight-Loss drug also calm a painful skin disease?
Symptom relief Not yet recruitingResearchers are testing an experimental drug called olatorepatide in adults with moderate to severe hidradenitis suppurativa who also live with overweight or obesity. Hidradenitis suppurativa causes painful lumps and tunnels under the skin. The trial compares olatorepatide with a…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
New supplement shows promise for fibromyalgia sufferers
Symptom relief Not yet recruitingThis study tests whether a supplement called FibroThol (containing 2-Aticyto Complex and D-ribose) can help reduce pain and other symptoms in people with fibromyalgia. About 200 adults aged 18 to 65 who have had fibromyalgia for at least a year and are already on standard medicat…
Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Can digital questionnaires improve life during pancreatic cancer therapy?
Symptom relief Not yet recruitingResearchers at MD Anderson Cancer Center are studying whether routine electronic symptom monitoring improves quality of life and care experience for patients with pancreatic adenocarcinoma receiving chemotherapy or radiation before surgery. About 200 adults with operable or local…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 21, 2026 18:00 UTC
-
Magnetic pulses to the brain target gambling cravings
Symptom relief Not yet recruitingResearchers at Sveti Ivan Psychiatric Hospital are testing whether high-frequency repetitive transcranial magnetic stimulation (rTMS) with the H7 coil reduces gambling disorder symptoms. The trial enrolls 60 men aged 18 to 64 who are starting treatment at a gambling disorder day …
Sponsor: Sveti Ivan Psychiatric Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
A single zoom class might ease cancer pain for american indians
Symptom relief Not yet recruitingThis trial tests whether a single, two-hour online class called Empowered Relief can help American Indian adults with cancer-related pain. Participants learn three pain relief skills, create a personal plan, and get access to a free audio app for daily practice. The study aims to…
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can an AI chatbot help cancer patients kick the habit?
Symptom relief Not yet recruitingResearchers are testing whether an AI chatbot on WeChat helps early-stage cancer patients quit smoking. The chatbot uses the Multi-Theory Model to offer personalized advice, emotional support, and habit tracking around the clock. The trial compares the chatbot with phone-based pr…
Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a personal navigator help young cancer patients through treatment?
Symptom relief Not yet recruitingResearchers at the University of North Carolina are testing a support program for young adults aged 18 to 39 who are receiving cancer treatment. A trained navigator contacts each participant at least once a month for four months by phone, text, email, or video, based on what the …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can adding common pain drugs reduce morphine needs in sickle cell crises?
Symptom relief Not yet recruitingAdults with sickle cell disease often face severe pain crises that require hospital treatment with intravenous morphine. This trial compares standard morphine treatment with combinations that add paracetamol, ketamine, or nefopam. Researchers want to see if these combinations eas…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Five-Session therapy ease distress and calm stress biology in Late-Stage breast cancer?
Symptom relief Not yet recruitingResearchers are testing a five-session meaning-centered psychotherapy called CASA in Puerto Rican patients with Stage III or IV breast cancer and their caregivers. The trial compares CASA with usual care in about 114 people to see whether the therapy reduces psychological distres…
Phase 1 • Sponsor: Ponce Medical School Foundation, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly weight drug quiet gout attacks?
Symptom relief Not yet recruitingResearchers are testing whether mazdutide, a weekly injected drug, reduces the number of gout flares in adults who have both obesity and gout. The study enrolls 30 people aged 18 to 65 with a BMI of at least 30 and at least two gout flares in the past six months. Everyone receive…
Phase 4 • Sponsor: Hongwei Jiang • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a video game teach cancer patients to tame their pain?
Symptom relief Not yet recruitingResearchers at Dana-Farber Cancer Institute are testing Healing Gardens, a mobile game that delivers pain-focused cognitive behavioral therapy and cancer pain education. The study enrolls 46 adults with advanced solid tumors who have chronic pain related to cancer or its treatmen…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can spiritual workshops ease Cancer's existential pain?
Symptom relief Not yet recruitingThis study tests a spiritual health program called PATH for cancer patients struggling with feelings of disconnection, loss of meaning, or existential distress. Twenty adults with any stage of cancer will attend six workshops combining role-playing, psychology, and dignity therap…
Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
Symptom relief Not yet recruitingThis trial tests whether an artificial intelligence chatbot can help men with prostate cancer better understand radiation therapy. Participants will use a plain-language chatbot alongside standard education from their care team. Researchers will measure changes in patients' confi…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a faster recovery plan get kids home sooner after ileostomy reversal?
Symptom relief Not yet recruitingResearchers compare two approaches to care after ileostomy reversal surgery in children. One group receives the Enhanced Recovery After Surgery (ERAS) protocol, which includes early feeding, early catheter removal, early walking, and multimodal pain control. The other group recei…
Sponsor: Children Hospital Faisalabad • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a sugary drink before Weight-Loss surgery speed up gut recovery?
Symptom relief Not yet recruitingResearchers are testing whether a carbohydrate-rich clear drink given two hours before bariatric surgery helps patients with metabolic syndrome recover normal gastrointestinal function faster. About 208 adults scheduled for gastric bypass or sleeve gastrectomy will be randomly as…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can electrical muscle stimulation boost exercise benefits after menopause?
Symptom relief Not yet recruitingResearchers are testing whether adding whole-body electromyostimulation (WB-EMS) to a supervised exercise program improves body composition, heart health, fitness, and quality of life in overweight or obese postmenopausal women. Thirty women aged 48 to 60 will join a 16-week prog…
Sponsor: High Institute of Sports and Physical Education of Kef • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Nerve-Block procedure tested against severe pancreatic and stomach cancer pain
Symptom relief Not yet recruitingResearchers are studying whether a procedure called fluoroscopy-guided transdiscal splanchnic nerve neurolysis can safely reduce severe upper abdominal pain in adults with pancreatic, gastric, or hepatobiliary cancer. Participants first receive a diagnostic nerve block with local…
Sponsor: Sahiwal medical college sahiwal • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a 10-Hour eating window fight cancer fatigue?
Symptom relief Not yet recruitingResearchers are testing whether time-restricted eating, where all food is eaten within a 10-hour window each day, can reduce fatigue and slow frailty in older adults living with prostate cancer or metastatic breast cancer. The trial enrolls 132 people aged 55 and older who typica…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?
Symptom relief Not yet recruitingMany people treated with aromatase inhibitors for early-stage breast cancer develop joint pain and stiffness that can make it hard to continue the therapy. This Phase II pilot study tests whether hydroxychloroquine, an anti-inflammatory drug often used for inflammatory joint cond…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Microwave needle tested as Scar-Free fix for benign breast lumps
Symptom relief Not yet recruitingResearchers are testing whether ultrasound-guided microwave ablation can safely treat breast fibroadenomas, which are non-cancerous lumps that can cause pain or change the shape of the breast. The procedure uses a thin needle to deliver heat that destroys the lump under local ane…
Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can tango rewire the brain? dance program tested for Parkinson's and dementia
Symptom relief Not yet recruitingResearchers at Emory University are studying a modified Argentine tango program called Adaptango for adults with Parkinson's disease, mild cognitive impairment, or dementia, alongside younger adults. Over three months, participants take part in biweekly choreographic sessions tha…
Sponsor: Emory University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a phone app help pancreatic cancer patients eat better during treatment?
Symptom relief Not yet recruitingResearchers are testing whether a digital nutrition app called STRONG, paired with remote dietitian counseling, is practical and helpful for adults with pancreatic ductal adenocarcinoma who are starting chemotherapy or radiation. About 80 participants join the study and are assig…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug shield kidneys from chemotherapy damage?
Symptom relief Not yet recruitingResearchers are testing an experimental drug called GMDTC in adults with solid tumors who have mild kidney problems caused by cisplatin chemotherapy. The trial aims to find out if GMDTC is safe, what side effects it causes, and how the body processes it. Participants receive cisp…
Phase 1 • Sponsor: Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a light bulb dial down chronic pain?
Symptom relief Not yet recruitingResearchers at the University of North Carolina at Chapel Hill are testing whether daily exposure to S-cone stimulating colored light can reduce pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants use programmed ligh…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could early palliative care reduce aggressive End-of-Life cancer treatments?
Symptom relief Not yet recruitingThis study looks at whether bringing in palliative care early during an unplanned hospital stay can reduce aggressive treatments at the end of life for people with advanced cancer. About 493 adults with metastatic digestive, gynecological, ENT, or sarcoma cancers will be randomly…
Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Starving brain tumors of blood before surgery
Symptom relief Not yet recruitingSome brain tumors, including meningiomas, hemangioblastomas, and certain metastases, have a rich blood supply that makes surgical removal difficult and risky. This study tests whether blocking the tumor's feeding blood vessels with a catheter procedure before surgery reduces blee…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a starch powder trick the gut into curbing teen appetite?
Symptom relief Not yet recruitingResearchers at Indiana University are testing whether a food carbohydrate powder made from raw corn and potato starch can raise levels of GLP-1, a gut hormone that helps people feel full. The trial enrolls 62 adolescents aged 12 to 18 with obesity. For two months, participants dr…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a Dietitian's plan help older pancreatic cancer patients feel better?
Symptom relief Not yet recruitingResearchers are testing whether personalised nutritional care from a trained dietitian improves quality of life for people aged 65 and older with pancreatic ductal adenocarcinoma. About 250 participants will be randomly assigned to either six months of individualised nutrition su…
Sponsor: Inna Chen, MD • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can leaving a sliver of tooth root save your smile after an implant?
Symptom relief Not yet recruitingResearchers compare two methods for replacing a missing front upper tooth with an implant right after extraction. One method, the Socket-Shield technique, leaves a thin piece of the tooth root in place to help protect the jawbone and gums. The other method uses the standard appro…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a single talk session help cancer patients quit smoking?
Symptom relief Not yet recruitingResearchers test whether adding one structured cognitive behavioral therapy session to standard brief quit-smoking advice helps cancer patients stop smoking. The trial enrolls 446 adults with cancer in Vietnam who smoked at diagnosis and still smoke. Everyone gets brief counselin…
Sponsor: Nguyen Duc Khoa, MD, PhD • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Ancient music therapy put to the test against anxiety in pancreatic cancer
Symptom relief Not yet recruitingThis trial tests whether a traditional Chinese music therapy, called Ziwu Liuzhu Five-Element Music Therapy, can reduce anxiety in people with pancreatic cancer who are undergoing chemotherapy. The study will enroll 320 patients with mild-to-moderate anxiety and randomly assign t…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Keyhole vs open surgery: which appendectomy works better for obese patients?
Symptom relief Not yet recruitingResearchers compare two surgical methods for removing an inflamed appendix in obese patients: laparoscopic (keyhole) surgery and traditional open surgery. The trial enrolls 166 obese adults with acute appendicitis, randomly assigning each to one of the two procedures. The main go…
Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can orange peel gel soothe radiation mouth sores?
Symptom relief Not yet recruitingResearchers are testing a gel made from orange peel extract to see if it can reduce the severity of mouth sores caused by radiation therapy in people with head and neck cancer. Thirty adults receiving radiation will be split into two groups: one gets the orange peel gel, the othe…
Sponsor: Alexandria University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can VR games restore lost vision in young brain tumor survivors?
Symptom relief Not yet recruitingThis study tests whether a virtual reality program can improve vision in 120 children, teens, and young adults who have lost part of their visual field (hemianopsia) after a brain tumor. Participants will use a VR headset at home for 8 weeks to do visual exercises. The goal is to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a simple IV drip replace nerve blocks for breast surgery pain?
Symptom relief Not yet recruitingResearchers are testing whether an intravenous lidocaine infusion works as well as a thoracic paravertebral nerve block for helping women recover after breast cancer surgery. The trial enrolls 112 adults scheduled for mastectomy or breast-conserving surgery. Participants receive …
Sponsor: Mahidol University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a common toxin calm Parkinson's shaking hands?
Symptom relief Not yet recruitingMany people with Parkinson's disease develop hand tremor that standard drugs cannot control. This Phase 3 trial tests whether botulinum toxin injections, guided by each patient's tremor pattern, can reduce that shaking. Participants receive either the toxin or a placebo injection…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Exercise after chemo: could a simple walking program protect your heart?
Symptom relief Not yet recruitingThis study looks at whether an 8-week aerobic exercise program can improve blood vessel function in women who have finished chemotherapy for non-metastatic breast cancer. Forty women will exercise three times a week for 30 minutes at a moderate pace. Researchers will measure arte…
Sponsor: Loyola University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Breathing your way to better heart health: new POTS study
Symptom relief Not yet recruitingThis study tests whether regular breathing exercises can improve symptoms of Postural Tachycardia Syndrome (POTS), a condition that causes dizziness and rapid heartbeat when standing. Twelve adults with POTS will practice breathing exercises daily for four weeks while researchers…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Shorter radiation course tested for advanced head and neck cancer
Symptom relief Not yet recruitingResearchers compare two palliative radiation schedules for people with incurable head and neck cancer. The standard Split Course takes several weeks and often causes hard-to-tolerate side effects. The study tests whether a shorter Quad Shot regimen can shrink tumors and ease symp…
Sponsor: Instituto Nacional de Cancerologia, Columbia • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could kids with bone cancer go home sooner after chemo?
Symptom relief Not yet recruitingThis study looks at whether children, teens, and young adults with newly diagnosed osteosarcoma can safely leave the hospital when their methotrexate levels are slightly higher than usual after standard chemotherapy. The goal is to shorten hospital stays without increasing side e…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Monthly shot aims to quiet sleep apnea and shed pounds
Symptom relief Not yet recruitingResearchers are testing whether a monthly injection of berobenatide can reduce the severity of obstructive sleep apnea and lower body weight in adults who have overweight or obesity and use a PAP breathing machine. The trial enrolls about 258 adults with moderate to severe sleep …
Phase 3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Robot leg training tuned to each child may build stronger knees in SMA
Symptom relief Not yet recruitingResearchers are testing a portable knee-training robot in children aged 6 to 12 with spinal muscular atrophy. Each child trains one leg with a flexible, individually tuned stiffness setting and the other leg with a rigid setting for up to 8 weeks. The trial compares how much knee…
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Hair-Thin electrodes tested to Fine-Tune brain stimulation
Symptom relief Not yet recruitingResearchers at Lund University are testing a new way to deliver deep brain stimulation using a cluster of very thin, flexible microelectrodes. The study includes up to 12 adults with Parkinson's disease or essential tremor who are already scheduled for standard deep brain stimula…
Sponsor: Lund University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a handheld breathing device and phone app help COPD patients breathe easier?
Symptom relief Not yet recruitingRESP-FIT tests whether a home-based breathing muscle training program, paired with a mobile app for symptom tracking and activity monitoring, can improve breathlessness, breathing strength, and physical activity in adults with COPD. Researchers are enrolling 288 adults aged 40 an…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a single psychedelic dose ease despair in advanced cancer?
Symptom relief Not yet recruitingResearchers are testing whether a single high dose of psilocybin, given alongside a structured talking therapy called PEARL, reduces depressive symptoms in adults with advanced cancer. The trial enrolls 46 people in Ontario with stage IV solid tumors, sarcoma, melanoma, endocrine…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can coloring mandalas improve life for cancer patients?
Symptom relief Not yet recruitingResearchers are testing whether mandala coloring can improve quality of life for people receiving cancer care. The trial enrolls 76 hospitalized cancer patients and assigns them to either a coloring group or a routine-care group. For three weeks, the coloring group uses a mandala…
Sponsor: Emine TARLABELEN KARAYTUĞ • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Lens showdown: which contact lens wins in dim light?
Symptom relief Not yet recruitingResearchers compare two approved soft contact lenses to see which provides better distance vision in low-light conditions. The study enrolls 150 adults aged 18 to 39 who already wear reusable spherical silicone hydrogel lenses. Participants wear each lens for two weeks in a rando…
Sponsor: Johnson & Johnson Vision Care, Inc. • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can acupuncture take the edge off hospital Workers' stress?
Symptom relief Not yet recruitingResearchers test traditional Chinese medicine body acupuncture in nurses, midwives, and doctors at an acute care hospital who report moderate or higher stress. Participants receive eight sessions over four weeks, with treatment chosen by TCM pulse and symptom patterns. The study …
Sponsor: Swiss University for Traditional Chinese Medicine • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Donor nerve grafts put to the test for restoring feeling after mastectomy
Symptom relief Not yet recruitingThis trial tests whether adding a donor nerve graft during implant-based breast reconstruction helps women regain breast and nipple sensation after nipple-sparing mastectomy. Each participant has one breast randomly chosen to receive the graft, while the other breast serves as a …
Phase 4 • Sponsor: Endeavor Health • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a home exercise plan steady balance in parkinson disease?
Symptom relief Not yet recruitingResearchers at Istanbul University are testing whether a structured home exercise program paired with self-management education helps adults with Parkinson disease improve balance, walking, hand dexterity, and quality of life. The trial enrolls 55 people aged 45 to 80 who have ha…
Sponsor: Istanbul University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can banding the esophagus stop reflux? a small trial tests the idea
Symptom relief Not yet recruitingResearchers are testing whether placing small bands in the lower esophagus can create a barrier against stomach acid and ease GERD symptoms. The trial enrolls people with symptomatic GERD who have not had previous reflux surgery. Participants undergo an endoscopic procedure to pl…
Sponsor: El Katib Hospital • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a chatbot and VR headset lower stress in cancer wards?
Symptom relief Not yet recruitingResearchers are testing a digital tool called Mindbot, a chatbot on the LINE messaging app that guides hospitalized cancer patients through a 10-minute mindfulness session with breathing exercises and virtual reality. The trial enrolls 66 adults with cancer who are staying in the…
Sponsor: Taipei Medical University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Coated braces wires put to the test: can a nanocoating speed up tooth straightening?
Symptom relief Not yet recruitingResearchers at Al-Azhar University are testing whether orthodontic archwires coated with zirconium dioxide nanoparticles move crowded teeth faster than standard uncoated wires. The trial enrolls 20 teenagers, ages 13 to 19, who have moderate crowding of the upper front teeth and …
Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a skin gel shrink stubborn birthmarks?
Symptom relief Not yet recruitingResearchers are testing whether a topical gel containing sirolimus can flatten raised epidermal nevi and even out their color. The study enrolls people aged 6 and older who have had stable, non-inflammatory epidermal nevi for at least three years. Participants apply the gel twice…
Early phase 1 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can six weeks of breathing training make Kids' lungs stronger?
Symptom relief Not yet recruitingResearchers are testing whether a six-week program of breathing-muscle training combined with high-intensity interval exercise improves diaphragm thickness, lung function, and aerobic fitness in boys aged 10 to 12 with obesity. Fifty boys are randomly assigned to the combined tra…
Sponsor: Gümüşhane Universıty • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can Self-Compassion training break the isolation of life with a stoma?
Symptom relief Not yet recruitingColorectal cancer patients who live with a stoma often face stigma, social anxiety, and loneliness. Researchers are testing a six-week mindfulness and self-compassion program adapted for these patients. The pilot trial enrolls 20 adults who have finished active treatment and spea…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a Sleep-Themed game help chemo patients rest better?
Symptom relief Not yet recruitingResearchers are testing whether a web-based game that teaches sleep hygiene can improve sleep quality and reduce fatigue in people receiving chemotherapy. The trial enrolls 56 adults undergoing chemotherapy who do not have a diagnosed sleep disorder. Half receive the gamified Sle…
Sponsor: Lokman Hekim University • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Massive 30-Year study aims to unlock secrets of diabetes and obesity
Knowledge-focused Not yet recruitingThis study will follow 1,000 people aged 8 to 65 who are overweight, have high blood sugar, or have metabolic issues. Researchers will collect blood, saliva, urine, and stool samples during routine clinic visits, along with questionnaires about diet, sleep, and mood. The goal is …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Fatty meals may trap vitamin e in the blood, study suggests
Knowledge-focused Not yet recruitingThis study investigates how eating three high-fat meals in a row changes vitamin E levels in the blood. Researchers will compare people with normal blood fats to those with high blood fats (hyperlipidemia). The goal is to understand whether fats in the blood can trap vitamin E, p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can hidden blood mutations ignite heart disease?
Knowledge-focused Not yet recruitingThis study investigates clonal hematopoiesis, an age-related condition where blood stem cells acquire mutations, and how it triggers inflammation linked to heart disease. Researchers will compare immune cells from healthy people, those with high-risk mutations, and patients with …
Sponsor: VASCage GmbH • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Four-Part check may reveal hidden malnutrition in sickest kids
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying how to identify malnutrition in critically ill children aged 1 month to 5 years admitted to a pediatric intensive care unit. The team uses a four-part ABCD approach that combines body measurements, blood markers, physical signs, and d…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Scientists probe why rheumatic pain feels different for everyone
Knowledge-focused Not yet recruitingResearchers want to understand the different ways pain works in people with rheumatic diseases such as lupus, rheumatoid arthritis, and Sjogren's syndrome. The study enrolls up to 225 people aged 9 to 85 who have or may have a rheumatic disease, plus healthy volunteers matched by…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Finger-Prick blood tests could let lung cancer patients skip clinic visits
Knowledge-focused Not yet recruitingResearchers are testing whether people with non-small cell lung cancer can collect their own small blood samples at home using a finger-prick kit. Participants receive standard treatment with docetaxel, paclitaxel, alectinib, or lorlatinib, and the samples measure how much cancer…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Breakfast showdown: High-Fat vs. High-Carb – which worsens blood fats?
Knowledge-focused Not yet recruitingThis study looks at how eating a high-fat or high-carb breakfast changes fat levels in the blood over 8 hours. Researchers will compare results among people with conditions like diabetes, fatty liver, or kidney disease, as well as healthy volunteers. Participants will have two ov…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Why do some leukemia patients develop dangerous blood clots?
Knowledge-focused Not yet recruitingResearchers are observing adults newly diagnosed with acute leukemia during their hospital stay to learn which factors raise the risk of venous thromboembolism, a serious blood clot condition. The study follows about 250 patients from admission to discharge or death, recording cl…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can regional data improve bone marrow transplant results for blood cancers?
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying adults with blood cancers who receive an autologous hematopoietic stem cell transplant, a procedure that uses a patient's own stem cells. The study follows 123 participants to measure survival, progression-free survival, complications…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can a High-Phenolic ancient grain rewire metabolism?
Knowledge-focused Not yet recruitingResearchers are testing whether whole grain sorghum improves immune and metabolic health in adults with excess weight, and whether phenolic compounds in the grain drive those effects. Thirty participants eat foods made from high-phenolic sumac sorghum, low-phenolic white sorghum,…
Sponsor: University of Nebraska Lincoln • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can Weight-Loss surgery ease a pain in the neck?
Knowledge-focused Not yet recruitingResearchers want to know whether weight loss from laparoscopic sleeve gastrectomy changes neck pain, posture, and neck function. The study follows about 25 adults scheduled for this weight-loss operation at one hospital. Participants complete neck questionnaires, strength and mot…
Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can a tiny fat sample predict childhood obesity?
Knowledge-focused Not yet recruitingResearchers want to know whether biological markers in blood and fat tissue can flag a young child's risk of becoming overweight later. The study enrolls 400 children under age 4 who are already scheduled for surgery, collecting a small blood sample and two tiny fat samples durin…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Your childhood may be driving your food choices: new study investigates
Knowledge-focused Not yet recruitingThis natural history study looks at how life events during childhood might affect eating behaviors and weight gain in adults. Researchers will observe 110 healthy volunteers aged 18 to 60, measuring food intake, physical activity, blood sugar, and body fat. Participants will also…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can a 20-minute HIIT session shift prostate cancer hormone levels?
Knowledge-focused Not yet recruitingThis study looks at how a short, home-based high-intensity workout affects steroid hormones in men with low-grade prostate cancer who are on active surveillance. About 49 men will do one supervised bodyweight HIIT session and provide saliva samples. The goal is to see if the exer…
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can a Once-Weekly shot cut the burden of hemophilia a?
Knowledge-focused Not yet recruitingResearchers are studying how switching to efanesoctocog alfa (ALTUVOCT), a long-acting factor VIII therapy given once a week, affects adults and children with severe or moderate hemophilia A in routine care. The study tracks factor use, treatment satisfaction, and quality of life…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Childhood obesity and early puberty: a new study seeks answers
Knowledge-focused Not yet recruitingThis study follows 400 children aged 5 to 7 with obesity or normal weight until age 12. Researchers will track puberty signs, hormones, genes, diet, and chemical exposures to see what predicts early puberty. No treatments are given; the goal is to gather information.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Can your nose predict brain health? new study tests smell and choices in HIV and addiction
Knowledge-focused Not yet recruitingThis study looks at how HIV and substance use disorder (SUD) affect the sense of smell and decision-making. Researchers will test 120 adults aged 18–65, including people with HIV, SUD, both, or neither. Participants will complete smell tests and computer tasks over two visits, an…
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
New scale aims to help IBD patients manage their own care
Knowledge-focused Not yet recruitingThis study is building a new questionnaire to measure how well people with inflammatory bowel disease (IBD) take care of themselves. Researchers will talk to 275 adults with Crohn's disease or ulcerative colitis to understand their self-care habits, then test the questionnaire to…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Your mood may be steering your choices: scientists track emotions to predict behavior
Knowledge-focused Not yet recruitingResearchers at the National Institute of Mental Health are studying how everyday feelings, like stress or frustration, influence decision-making. They will follow 420 adults aged 18 to 55, including healthy volunteers and people with varying levels of depression, anxiety, or addi…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
Blood test may reveal why some MDS patients feel worn out on luspatercept
Knowledge-focused Not yet recruitingResearchers are studying blood samples from 150 adults with lower-risk myelodysplastic syndromes (MDS) who receive luspatercept, a drug that boosts red blood cell production. The goal is to find metabolites and other biomarkers linked to fatigue, a common side effect of the treat…
Phase 4 • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Sep 21, 2026 18:00 UTC
-
A tiny touch test aims to map lost sensation in the throat
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are studying how well a calibrated touch device measures sensation in the larynx and throat. The study includes adults with larynx or throat disorders, including those whose condition followed radiation or other cancer tr…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Desk jobs and aching bodies: what Lawyers' activity levels reveal
Knowledge-focused Not yet recruitingResearchers at Suleyman Demirel University are surveying lawyers registered with the Isparta Bar Association to understand how physical activity, stress, burnout, and job satisfaction relate to musculoskeletal pain. About 102 lawyers with at least five years of experience answer …
Sponsor: Suleyman Demirel University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can Real-World data match trial results for pembrolizumab in Triple-Negative breast cancer?
Knowledge-focused Not yet recruitingResearchers in Korea are reviewing medical records from about 2,000 patients with triple-negative breast cancer who received pembrolizumab plus chemotherapy before surgery. The study measures how many patients had no detectable cancer left in their breast and lymph nodes at surge…
Sponsor: Yeon Hee Park • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Arkansas study tracks Moms' diets to boost baby health
Knowledge-focused Not yet recruitingThis study follows 125 pregnant women from 30 weeks of pregnancy through their baby's first year. Researchers want to learn how diet, food access, and other social factors affect mothers' health, breastfeeding success, and baby growth. Participants will complete remote visits and…
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
Knowledge-focused Not yet recruitingResearchers are observing 300 adults aged 60 and older with inflammatory bowel disease who are starting an advanced therapy chosen by their usual care team. The study tracks immune-aging markers such as CD4/CD8 ratio and IL-6, along with frailty and nutrition, over 52 weeks. The …
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Do GLP-1 Weight-Loss drugs change how teens eat and feel?
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are following 100 adolescents and young adults, ages 12 to 21, who are starting GLP-1 weight-loss drugs like Ozempic, Wegovy, or Mounjaro. Over one year, participants answer online surveys about their eating behaviors and…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
French study to reveal who really benefits from obesity drug semaglutide
Knowledge-focused Not yet recruitingThis study will follow 3,000 French patients with severe or complicated obesity who are taking semaglutide (Wegovy) as part of an early access program. Researchers will track weight changes, treatment patterns, and well-being over time using questionnaires. The goal is to underst…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Walking memory tests may reveal early Parkinson's clues
Knowledge-focused Not yet recruitingResearchers are studying whether navigational memory fades before other spatial memory in people with Parkinson's disease and related conditions. The pilot includes 80 participants: those with mild or advanced Parkinson's, those with parkinsonism, and healthy volunteers. Particip…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
30 patients to test if nutrition tracking boosts wound healing
Knowledge-focused Not yet recruitingThis pilot study will check if it's possible to collect useful nutrition and health information from 30 adults with diabetic foot ulcers. Researchers want to see if they can recruit enough people and gather complete data. The goal is to learn about patients' diet, body compositio…
Sponsor: Hvidovre University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
Knowledge-focused Not yet recruitingThis study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Fitbit study aims to decode recovery after breast reconstruction
Knowledge-focused Not yet recruitingThis study will give 50 women a Fitbit Inspire 3 to wear before and after DIEP flap breast reconstruction surgery. Researchers will track steps, heart rate, and sleep, and compare that data with short questionnaires about recovery. The goal is to learn more about how patients rec…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Which contact method best warns families of hidden cholesterol danger?
Knowledge-focused Not yet recruitingThis study compares two approaches to notify relatives of people diagnosed with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. One method lets patients share information themselves; the other has the study team contact relatives directly. R…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New survey aims to better understand ovarian cancer Patients' daily lives
Knowledge-focused Not yet recruitingThis study is testing a new questionnaire (called the QLQ-OV39) to see how well it measures quality of life in people with ovarian cancer. About 50 adults with early or advanced ovarian cancer will fill out the questionnaire and give feedback. The goal is to make sure the questio…
Sponsor: Helios University Hospital Wuppertal • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a smartwatch help cancer patients during chemo and radiation?
Knowledge-focused Not yet recruitingThis study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploadi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists to examine liver tissue after gene therapy for hemophilia
Knowledge-focused Not yet recruitingThis observational study will take small liver samples from 8 adults with hemophilia A or B who had gene therapy at least 6 months ago. Researchers want to see how the gene therapy affected liver cells, including how many cells still carry the therapy and whether there is any liv…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The hidden handshake that decides whether an embryo implants
Knowledge-focused Not yet recruitingResearchers want to understand why most IVF embryo transfers fail to implant and what goes wrong in pregnancies complicated by preeclampsia. They will collect small tissue samples from the womb lining of up to 500 women aged 18 to 50 who are already scheduled for a diagnostic hys…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
Knowledge-focused Not yet recruitingMultiple myeloma is a blood cancer in which abnormal plasma cells build up in bone marrow, and inflammation may shape how the disease behaves. Researchers at Assiut University plan to study 60 people newly diagnosed with myeloma before any anti-myeloma treatment begins. They will…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can Real-World data reveal the best rectal cancer treatment?
Knowledge-focused Not yet recruitingThis observational study gathers information from routine care on how localized rectal cancer is treated across Austrian hospitals. It aims to document the variety of treatment approaches, including total neoadjuvant therapy and immunotherapy, and their outcomes. By analyzing thi…
Sponsor: Austrian Breast & Colorectal Cancer Study Group • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can gene therapy zolgensma safely improve motor skills in SMA?
Knowledge-focused Not yet recruitingThis study follows 80 people with spinal muscular atrophy (SMA) in Japan who receive Zolgensma (onasemnogene abeparvovec) as an intrathecal injection. The goal is to track safety issues, such as liver problems or blood clotting abnormalities, and to measure changes in motor funct…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Triple-Pronged attack on gut inflammation put to the test
Knowledge-focused Not yet recruitingResearchers are testing whether blocking three inflammation pathways at once (TL1A, IL-23, and α4β7) calms inflamed intestinal tissue more effectively than blocking each pathway alone. The study enrolls 30 people: 10 with ulcerative colitis, 10 with Crohn's disease, and 10 withou…
Sponsor: PhoenixLAB srls • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
AI nutrition coach for Moms-to-Be: a new study tests a Chatbot's helpfulness
Knowledge-focused Not yet recruitingThis study will test if an AI chatbot can give helpful nutrition advice to pregnant women. About 100 women will either use the chatbot or get standard care. The goal is to see if the chatbot is easy to use and if it helps improve diet and knowledge about conditions like gestation…
Sponsor: Hong Kong Metropolitan University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study tracks hidden dangers of common leukemia drug
Knowledge-focused Not yet recruitingThis study will follow 200 children with acute lymphoblastic leukemia or lymphoma to learn more about the short- and long-term side effects of asparaginase drugs. Researchers will track how often serious toxicities occur during standard treatment and a newer therapy called SJALL2…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Inside the metabolic chamber: scientists probe extreme obesity
Knowledge-focused Not yet recruitingThis study will measure how the body uses energy and burns fat in 10 people with extreme obesity (BMI of 60 or higher). Participants will spend 23 hours in a special metabolic chamber and drink a labeled water to track energy use over a week. The goal is to better understand meta…
Sponsor: Pennington Biomedical Research Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The 20-Minute squeeze: how eye injections push pressure up
Knowledge-focused Not yet recruitingAnti-VEGF injections treat conditions like diabetic macular edema, age-related macular degeneration, and retinal vein occlusion by adding fluid inside the eye, which can briefly raise eye pressure. This observational study at Assiut University follows 50 adults receiving these ro…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study aims to slash cervical cancer deaths in HIV-positive women
Knowledge-focused Not yet recruitingThis study tests better ways to screen and treat cervical cancer in women living with HIV in Kenya, who face a much higher risk. Researchers will use HPV self-testing, care navigators, and a mobile app to help more women get diagnosed and treated. The goal is to find strategies t…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Do social factors decide who completes lymphoma treatment?
Knowledge-focused Not yet recruitingResearchers are examining health records from adults diagnosed with diffuse large B-cell lymphoma, a fast-growing blood cancer, across multiple UK hospitals. The study asks whether a patient's ethnicity, level of socioeconomic deprivation, and other health conditions influence ho…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Does your morning coffee stir up heart rhythm trouble?
Knowledge-focused Not yet recruitingResearchers want to know whether caffeine consumption is linked to irregular heartbeats and daily physical activity in adults with heart failure, reduced left ventricular ejection fraction, and an implantable cardioverter-defibrillator (ICD). About 170 participants fill out a one…
Sponsor: Jean-Benoît Le Polain de Waroux • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
Knowledge-focused Not yet recruitingThis study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Why do some children arrive at the ER with a racing or skipping heart?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are studying how often children who come to the emergency department have an abnormal heart rhythm. The study includes children aged 1 month to 18 years who arrive with symptoms such as palpitations, chest pain, fainting, or trou…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a DASH diet change your gut bugs and help you lose weight?
Knowledge-focused Not yet recruitingThis study will give 28 women with obesity either a calorie-restricted DASH diet or a standard American diet for 4 weeks. Researchers will track weight changes and analyze stool samples to see how diet affects gut bacteria and related health markers. The goal is to understand how…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can we end stigma in cancer care? a new study investigates
Knowledge-focused Not yet recruitingThis study asks whether healthcare providers in cancer centers hold negative attitudes toward patients with mental disorders, and what factors influence those views. Researchers will survey about 1,000 oncology professionals using a stigma questionnaire and interview some of them…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New MRI technique aims to spot kidney transplant rejection early
Knowledge-focused Not yet recruitingThis study will use advanced MRI scans to look at kidney transplants in 140 patients. The goal is to see if MRI can measure how well the kidney is working and tell the difference between stable function and problems like rejection. Researchers hope this could lead to a non-invasi…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare ebola cousin under the microscope as doctors chart its deadly course
Knowledge-focused Not yet recruitingFiloviruses such as Ebola and Marburg cause severe hemorrhagic fevers with high death rates, and doctors know little about rare types like Bundibugyo virus. This observational study follows patients in France with confirmed filovirus disease to record how the illness unfolds. Res…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Mapping how thyroid tumors spread and what surgery leaves behind
Knowledge-focused Not yet recruitingResearchers at Sohag University Hospitals are reviewing the medical records of 30 people treated for papillary thyroid cancer, the most common type of thyroid cancer. The study examines how far tumors extended beyond the thyroid gland and which complications appeared soon after s…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a simple ultrasound tell surgeons where tumor ends and healthy brain begins?
Knowledge-focused Not yet recruitingThis Mayo Clinic study will test whether a special ultrasound technique, called shear wave elastography, can measure how stiff brain tumors are compared to healthy brain tissue during surgery. Researchers will enroll 30 adults with newly diagnosed or recurrent brain tumors. The g…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to uncover hidden danger in stem cell transplants
Knowledge-focused Not yet recruitingThis study will follow 85 adults receiving stem cell transplants to track a serious but often missed complication called TA-TMA. Researchers want to find out how common it is and how it affects survival. Participants will provide blood samples and have standard follow-up care.
Sponsor: Manuel Ricardo Espinoza-Gutarra • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a phone app help end HIV stigma? south africa trial tests U=U education
Knowledge-focused Not yet recruitingThis study tests whether a video app that explains 'Undetectable = Untransmittable' (U=U) can help people with HIV stay on treatment and keep the virus under control. About 880 people from clinics in South Africa will use the app during counseling. The goal is to see if better un…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Canadian study aims to unlock secrets of cancer immunotherapy
Knowledge-focused Not yet recruitingThis study collects tumor tissue and blood samples from 120 cancer patients who are receiving or will receive immunotherapy. The samples will be stored in a biobank for future research to better understand how these treatments work. No direct treatment is given; the goal is to ga…
Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a video keep thyroid cancer patients on track after surgery?
Knowledge-focused Not yet recruitingAfter thyroid surgery for differentiated thyroid cancer, patients often need to take thyroid hormone at doses that keep TSH in a specific target range. Researchers at West China Hospital are testing whether adding a short educational video to standard instructions helps patients …
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans and biosamples: mapping why OCD looks so different in every person
Knowledge-focused Not yet recruitingResearchers at Shanghai Mental Health Center are following 500 people with obsessive-compulsive disorder to see how symptoms, daily functioning, and treatment responses change over time. The study includes adults aged 18 to 60, including some who have never received OCD treatment…
Sponsor: Shanghai Mental Health Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Personalized antibiotic dosing could save lives in the ICU
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Many ICU patients don't get enough of the drug because their bodies process it differently. The researchers will test a personalized dosing plan to keep…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Why does esophageal cancer come back after treatment? researchers search medical records for clues
Knowledge-focused Not yet recruitingResearchers are reviewing medical records of 100 people with esophageal squamous cell carcinoma who received immunotherapy plus chemotherapy before surgery to remove the cancer. The study examines when and where cancer returns and which patient traits, treatment details, scan res…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans reveal why fatty foods repel anorexia patients
Knowledge-focused Not yet recruitingThis study looks at how the brains of women with anorexia nervosa respond to fatty food smells and images. Researchers will use brain scans to compare their reactions to those of healthy women. The goal is to understand why fatty foods cause aversion, which could help improve fut…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can exercise and Self-Control shield kids from binge eating?
Knowledge-focused Not yet recruitingResearchers at the University of Texas at Dallas are studying how physical activity, sedentary behavior and self-control relate to loss of control eating in children. The study follows 200 children aged 10 to 12 for three years, using brain scans, activity monitors, and real-time…
Sponsor: The University of Texas at Dallas • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
AI could slash MRI scan times without sacrificing quality
Knowledge-focused Not yet recruitingThis study explores whether artificial intelligence can help perform high-field whole-body MRI scans faster while keeping image quality high. Researchers will compare standard MRI sequences with AI-accelerated versions in 600 adults undergoing screening for prostate, lung, or vas…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Could years of eye injections weigh down the upper eyelid?
Knowledge-focused Not yet recruitingDoctors use anti-VEGF injections to treat retinal diseases such as age-related macular degeneration and diabetic macular edema, and patients often need these shots for years. During each injection, a small tool holds the eyelids open, stretching the upper lid. Researchers want to…
Sponsor: Abdulkadir Küçük • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Is your nose fueling infected eczema and scabies sores?
Knowledge-focused Not yet recruitingResearchers are studying where the bacteria that infect skin sores come from in people with scabies or atopic dermatitis. They will compare bacteria grown from infected skin lesions with bacteria from nasal swabs to see if the same species appear in both places. A group of health…
Sponsor: Istanbul Medeniyet University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Hidden bacteria in prostate tumors may shape how the immune system fights cancer
Knowledge-focused Not yet recruitingResearchers at Anhui Medical University are studying bacteria found inside prostate tumors and how they relate to the immune system. The study uses leftover tissue samples and archived slides from about 100 men with prostate cancer or benign prostate disease. Scientists will sequ…
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Patients and staff team up to redesign hospital clinics for sensory needs
Knowledge-focused Not yet recruitingThis project at King's College London asks how hospital outpatient departments can work better for people with neurofibromatosis who also have sensory challenges. About 30 patients, carers, and staff from Guy's and St Thomas' NHS Foundation Trust take part in interviews, observat…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Prostate tumors hide a Nerve-Fueled neighborhood, and scientists are mapping it
Knowledge-focused Not yet recruitingResearchers at Anhui Medical University are studying how prostate cancer invades nerves, a feature linked to aggressive tumors and recurrence after surgery. They plan to collect tissue and clinical data from about 120 prostate cancer patients and compare nerve-invaded areas, ordi…
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Can Drug-Level testing personalize cystic fibrosis treatment?
Knowledge-focused Not yet recruitingResearchers are studying how the cystic fibrosis drugs elexacaftor, tezacaftor and ivacaftor move through the body. The trial enrolls people aged 6 and older with cystic fibrosis who carry at least one F508del mutation and already take this drug combination. Participants keep the…
Phase 4 • Sponsor: Istituto Giannina Gaslini • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Could metabolic syndrome shape the course of rare blood cancers?
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying whether metabolic syndrome, a cluster of conditions like high blood pressure and high blood sugar, relates to the clinical course of chronic Philadelphia-negative myeloproliferative neoplasms. These are rare blood cancers where the bo…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Why do some kids catch every cold? a 1,200-Child study hunts for immune clues
Knowledge-focused Not yet recruitingResearchers are following about 1,200 children in Zhejiang Province, China, from birth through age 7 to understand how the immune system develops and why some children get more respiratory infections or asthma. The study includes healthy children, children with a history of serio…
Sponsor: Zhejiang Provincial Center for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Flu's journey: scientists track how influenza passes between people
Knowledge-focused Not yet recruitingResearchers at Emory University are running a study to see whether influenza A or B spreads from adults who caught the flu in the community to healthy adults under controlled hospital conditions. Instead of using a lab-made flu strain, the study uses naturally infected donors as …
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can augmented reality make dental surgery more precise?
Knowledge-focused Not yet recruitingResearchers at the University of Bari Aldo Moro are testing whether augmented reality can help dentists perform oral surgery and orthodontic work more accurately. The study includes 10 healthy adults over 18 who need tooth extractions, dental implants, or braces. Before treatment…
Sponsor: University of Bari Aldo Moro • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
A routine calcium reading could reveal how sick a sepsis patient really is
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying whether ionized calcium levels, measured from a routine blood sample when a patient enters the ICU, can signal how severe sepsis or septic shock is. The study follows 160 adults admitted to intensive care within 24 hours of presentati…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Why does lung surgery leave some patients breathless? glasgow team probes the right heart
Knowledge-focused Not yet recruitingSome people who have keyhole lung cancer surgery develop lasting breathlessness and struggle with gentle exercise, even if their breathing was fine before. Researchers suspect the right side of the heart, which pumps blood to the lungs, may be weakened by the extra pressure it fa…
Sponsor: University of Glasgow • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
How do HIV drugs behave when kidneys fail? study measures blood levels
Knowledge-focused Not yet recruitingResearchers are studying how the HIV combination pill Descovy, which contains tenofovir alafenamide and emtricitabine, moves through the bodies of people with HIV who also have advanced chronic kidney disease. About 50 adults with stage 3b or stage 4 kidney disease will take part…
Sponsor: King's College Hospital NHS Trust • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Could Nutri-Score menu labels be gentler than calorie counts for people with eating disorders?
Knowledge-focused Not yet recruitingResearchers at the University of Liverpool are exploring how different menu labels affect food choices and feelings in adults with eating disorders, common mental health conditions like anxiety or depression, and no mental health diagnosis. Participants order a meal from a simula…
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can a Pre-Surgery checklist predict who will still have reflux after fundoplication?
Knowledge-focused Not yet recruitingLaparoscopic fundoplication relieves reflux for most GERD patients, but 10 to 30 percent still have symptoms or side effects afterward. Researchers at Minia University Hospitals follow 470 adults scheduled for this keyhole surgery, measuring ten factors before the operation such …
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Doctors worldwide vote to set fair rules for cancer patients in intensive care
Knowledge-focused Not yet recruitingHospitals lack agreed rules for when a person with cancer should go to the intensive care unit (ICU) and when they are well enough to leave. This project brings together 30 to 40 cancer and critical care experts from around the world to vote on draft statements about ICU care. Th…
Sponsor: Onco Critical Care Society • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Nighttime CO2 buildup: a hidden clue in sleep apnea?
Knowledge-focused Not yet recruitingResearchers at a French sleep center are studying adults with obesity who are referred for a sleep study because of suspected obstructive sleep apnea. The team measures how much carbon dioxide builds up in the blood overnight using a skin sensor, then compares that cumulative exp…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Brain tumor or aneurysm first? study weighs the safer sequence
Knowledge-focused Not yet recruitingResearchers are observing patients in China who have both a tumor in the sellar region of the brain and an unruptured intracranial aneurysm. The study compares three approaches: removing the tumor before treating the aneurysm, treating the aneurysm before removing the tumor, or r…
Sponsor: Cheng sen • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Sugar tracer reveals how immune cells fuel up in the ICU
Knowledge-focused Not yet recruitingResearchers at Vanderbilt University Medical Center want to understand how immune cells use glucose, the body's main sugar, during critical illness. They give 25 adult ICU patients an intravenous infusion of a non-radioactive carbon-13 glucose tracer over a few hours. Then they c…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Prison walls may not stop Animal-Borne diseases
Knowledge-focused Not yet recruitingResearchers are measuring how often five animal-borne infections appear among inmates at the French Guiana Correctional Facility. The study follows newly arrived adults for up to 12 months, testing for Q fever, leptospirosis, Chagas disease, histoplasmosis, and toxoplasmosis. The…
Sponsor: Centre Hospitalier de Cayenne • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC